0001493152-21-012128.txt : 20210518 0001493152-21-012128.hdr.sgml : 20210518 20210518160618 ACCESSION NUMBER: 0001493152-21-012128 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20210403 FILED AS OF DATE: 20210518 DATE AS OF CHANGE: 20210518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERCONDUCTOR TECHNOLOGIES INC CENTRAL INDEX KEY: 0000895665 STANDARD INDUSTRIAL CLASSIFICATION: RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663] IRS NUMBER: 770158076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-21074 FILM NUMBER: 21935999 BUSINESS ADDRESS: STREET 1: 15511 W. STATE HWY 71 STREET 2: SUITE 110-105 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-650-7775 MAIL ADDRESS: STREET 1: 15511 W. STATE HWY 71 STREET 2: SUITE 110-105 CITY: AUSTIN STATE: TX ZIP: 78738 10-Q 1 form10-q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended April 3, 2021

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission File Number 0-21074

SUPERCONDUCTOR TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)

Delaware		77-0158076
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

15511 W State Hwy 71, Suite 110-105, Austin, Texas 78738

(Address of principal executive offices & zip code)

(512) 650-7775

(Registrant’s telephone number including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]		Accelerated filer [ ]		Non-accelerated filer [X]
Smaller reporting company [X]				Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] or No [X]

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001		SCON		OTCQB

We had 3,151,780 shares of our common stock outstanding as of the close of business on May 11, 2021.

SUPERCONDUCTOR TECHNOLOGIES INC.

INDEX TO FORM 10-Q

Three Months Ended April 3, 2021

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS		1

PART I - FINANCIAL INFORMATION
	ITEM 1. Financial Statements (unaudited)
	Condensed Consolidated Statements of Operations	2
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Cash Flows	4
	Notes to Unaudited Condensed Consolidated Financial Statements.	5
	ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
	ITEM 3. Quantitative and Qualitative Disclosures About Market Risk	18
	ITEM 4. Controls and Procedures	18

PART II - OTHER INFORMATION		19
	ITEM 1. Legal Proceedings	19
	ITEM 1A. Risk Factors	19
	ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds	19
	ITEM 3. Defaults Upon Senior Securities	19
	ITEM 4. Mine Safety Disclosures	19
	ITEM 5. Other Information	19
	ITEM 6. Exhibits	19

SIGNATURES		20

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for these forward-looking statements. Our forward-looking statements relate to future events or our future performance and include, but are not limited to, statements concerning our business strategy, future commercial revenues, market growth, capital requirements, new product introductions, expansion plans and the adequacy of our funding. Other statements contained in this Report that are not historical facts are also forward-looking statements. We have tried, wherever possible, to identify forward-looking statements by terminology such as “may,” “will,” “could,” “should,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and other comparable terminology.

We caution investors that any forward-looking statements presented in this Report, or that we may make orally or in writing from time to time, are based on the beliefs of, assumptions made by, and information currently available to, us. Such statements are based on assumptions and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance and some will inevitably prove to be incorrect. As a result, our actual future results can be expected to differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on past forward-looking statements, which are based on known results and trends at the time they are made, to anticipate future results or trends.

We have included disclosures throughout this Report that relate to our business as it was conducted prior to the planned merger and asset dispositions described below. Readers are cautioned that both historical and forward looking disclosures regarding our business must be read in conjunction with the information regarding the planned merger and asset dispositions, because some disclosures regarding historical operations may not be indicative of future or current operations and plans. In particular, but without limitation, the reference to our historical business operations regarding our HTS wire should not be viewed as a statement that such operations continue to this day. Please see “Our Future Business” for additional important information.

Some of the risks and uncertainties that may cause our actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include the following:

	●	our planned merger with Allied Integral United, Inc. is subject to various uncertainties and risks and to conditions that have not yet been satisfied and there is no assurance the merger will be consummated;

	●	if we fail to complete our merger with Allied Integral United, Inc. we will have limited business options available as we have sold significant portions of our operating assets, and will likely need to seek bankruptcy protection;

	●	our limited cash and a history of losses;

	●	our need to raise additional capital or complete a strategic alternative for the company. If we are unable to raise capital our ability to implement our current strategic plan and ultimately our viability as a company could be adversely affected;

	●	the impact of any financing activity on the level of our stock price;

	●	the dilutive impact of any issuances of securities to raise capital;

	●	cost and uncertainty from compliance with environmental regulations;

	●	the impact on the level of our stock price due to our September 10, 2020 1-for10 reverse stock split and the NASDAQ decision to delist our common stock effective February 12, 2021; and

	●	local, regional, national and international economic conditions and events, and the impact they may have on us and our customer.

For further discussion of these and other factors see, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” in this Report.

This Report and all subsequent written and oral forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. We do not undertake any obligation to release publicly any revisions to our forward-looking statements to reflect events or circumstances after the date of this Report.

PART I

FINANCIAL INFORMATION

Item 1. Financial Statements

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended
	April 3, 2021			March 28, 2020

Commercial product revenues	$	-		$	10,000
Government contract revenues		-			174,000
Total revenues		-			184,000

Costs and expenses:
Cost of commercial product revenues		-			190,000
Cost of government contract revenues		-			71,000
Research and development		-			178,000
Selling, general and administrative		569,000			825,000

Total costs and expenses		569,000			1,264,000

Loss from operations		(569,000	)		(1,080,000	)

Other Income and Expense:
Other income		-			1,000

Net loss	$	(569,000	)	$	(1,079,000	)

Basic and diluted net loss per common share	$	(0.18	)	$	(0.56	)

Basic and diluted weighted average number of common shares outstanding		3,151,780			1,927,279

See accompanying notes to the unaudited condensed consolidated financial statements.

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	April 3,2021			December 31, 2020
	(Unaudited)			(See Note)
ASSETS

Current Assets:
Cash and cash equivalents	$	1,291,000		$	1,276,000
Inventories, net		68,000			68,000
Prepaid expenses and other current assets		19,000			76,000
Total Current Assets		1,378,000			1,420,000

Preferred interest in real estate		1,600,000			1,600,000
Total Assets	$	2,978,000			3,020,000

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	224,000		$	180,000
Accrued expenses		30,000			135,000
Total Current Liabilities		254,000			315,000
Long term debt		468,000			-
Total Liabilities		722,000			315,000

Commitments and Contingencies (Notes 5 and 6)

Stockholders’ Equity:
Preferred stock, $.001 par value, 2,000,000 shares authorized, 328,925 and 328,925 shares issued and outstanding, respectively		-			-
Common stock, $.001 par value, 25,000,000 shares authorized, 3,151,780 and 3,151,780 shares issued and outstanding, respectively		3,000			3,000
Capital in excess of par value		334,752,000			334,632,000
Accumulated deficit		(332,499,000	)		(331,930,000	)
Total Stockholders’ Equity		2,256,000			2,705,000
Total Liabilities and Stockholders’ Equity	$	2,978,000		$	3,020,000

See accompanying notes to the unaudited condensed consolidated financial statements.

Note – December 31, 2020 balances were derived from audited financial statements.

SUPERCONDUCTOR TECHNOLOGIES INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended
	April 3, 2021			March 28, 2020

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$	(569,000	)	$	(1,079,000	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		-			38,000
Stock-based compensation expense		-			21,000
Gain from sale of property and equipment		-			(510,000	)
Write-down of intangibles		-			134,000
Obsolete inventory		-			190,000
Changes in assets and liabilities:
Accounts receivable		-			(124,000	)
Inventories		-			5,000
Prepaid expenses and other current assets		(57,000	)		(58,000	)
Accounts payable, accrued expenses and other current liabilities		173,000			(87,000	)
Net cash used in operating activities		(453,000	)		(1,470,000	)

CASH FLOWS FROM INVESTING ACTIVITIES:
Net proceeds from the sale of patents, property and equipment		-			1,212,000
Net cash provided by investing activities		-			1,212,000

CASH FLOWS FROM FINANCING ACTIVITIES:
Bank loan		468,000			-
Net proceeds from the exercise of warrants		-			1,388,000
Net cash provided by financing activities		468,000			1,388,000

Net increase in cash and cash equivalents		15,000			1,130,000
Cash and cash equivalents at beginning of period		1,276,000			713,000
Cash and cash equivalents at end of period	$	1,291,000		$	1,843,000

See accompanying notes to the unaudited condensed consolidated financial statements.

SUPERCONDUCTOR TECHNOLOGIES INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.General

Please see “Our Future Business” below regarding material information and updates that in many material respects superseded and modify the following general business description.

Superconductor Technologies Inc (“STI”) was a leading company in developing and commercializing high temperature superconductor (“HTS”) materials and related technologies. Superconductivity is the unique ability to conduct electricity with little or no resistance when cooled to “critical” temperatures. HTS materials are a family of elements that demonstrate superconducting properties at temperatures significantly warmer than previous superconducting materials. Electric currents that flow through conventional conductors encounter resistance. This resistance requires power to overcome and generates heat. HTS materials can substantially improve the performance characteristics of electrical systems, reduce power loss, and lower heat generation providing extremely high current carrying density and zero resistance to direct current.

We were established in 1987 shortly after the discovery of HTS materials. Our stated objective was to develop products based on these materials for the commercial marketplace.

After analyzing the market opportunities available, we decided to develop products for the utility and telecommunications industries.

Our initial product was completed in 1998 and we began delivery to a number of wireless network providers. In the following 13 years, we continued to refine and improve the platform, with the primary focus on improving reliability, increasing performance and runtime, and most importantly, removing cost from the manufacturing process of the required subsystems. Our cost reducing efforts led to the invention of our proprietary, high-yield and high throughput HTS material deposition manufacturing process.

In early 2018, we announced the concentration of our future HTS Conductus® wire product development efforts on NGEM to capitalize on several accelerating energy megatrends. This refined focus is very synergistic with our program with the Department of Energy (DOE) award for the development of superconducting wire to enable NGEM.

On January 28, 2020, we announced a cost reduction plan for the purpose of aligning our personnel needs and capital requirements as we explored strategic alternatives previously announced. We have maintained operations of our Sapphire Cryocooler cryogenics initiatives while ceasing additional manufacturing of our HTS Conductus wire. The plan also included a 70% employee workforce reduction.

Subsequent to the announcement on January 28, 2020 about our cost reduction plan, we started the process of selling, in separate transactions, assets that we deemed non-essential going forward. The latest such transaction entered into on March 5, 2020, when considered in combination with the prior transactions since January 28, 2020, may be deemed a material definitive purchase agreement for sales of various production, R&D, and testing equipment and selected intellectual property related primarily to our superconducting wire initiative. The aggregate sales prices of the post January 28th transactions was approximately $1,075,000, all sold to purchasers having no affiliation with us.

As a result of these sales, we no longer have the ability to resume HTS wire operations without significant new investments and restructured operations and a new HTS wire business plan, neither of which we currently intend to pursue, as we instead focus our efforts on completing the Merger (as defined below).

Our Future Business

On February 26, 2020, we entered into a definitive merger agreement with Allied Integral United, Inc. (which will change its name to, and is therefore referred herein as, “Clearday”), a privately-held company dedicated to delivering next generation longevity care and wellness services, whereby our wholly-owned subsidiary will merge with and into Clearday in a stock-for-stock transaction with Clearday (the “Merger”), with Clearday surviving and becoming our wholly-owned subsidiary, we will then change our name to Clearday, Inc (the “Merger Agreement”).

As previously disclosed, on May 12, 2020, the Merger Agreement was amended by the parties to (i) add a covenant that the parties shall use their commercially reasonable efforts to cause STI to at all times remain listed on the Nasdaq Capital Market (or higher tier) and that if STI ceases to be listed on the Nasdaq Capital Market then the parties shall (including after the closing of the Merger) use their commercially reasonable efforts to cause STI to become listed on either the Nasdaq Capital Market or the NYSE MKT as promptly as reasonably possible, (ii) remove the conditions to closing the Merger that Nasdaq must determine that all listing deficiencies have been cured and determine to approve the listing of STI’s common stock on the Nasdaq and remove any other provisions in the Merger Agreement of like effect, (iii) extend the “outside date” for the Merger to close until the close of business on September 21, 2020 and (iv) require a customary tax representation letter from STI as a closing condition

As previously disclosed, due to our failure to comply with its listing conditions, the Nasdaq Stock Market notified us that it intended to complete the delisting of our common stock by filing a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission, which it did on February 2, 2021. Our common stock is no longer listed on a National Securities Exchange. Our stock trades on the OTC QB Market.

As also previously disclosed, we announced that, although the “outside date” of our Merger Agreement with Clearday has expired, both the Company and Clearday intended to finalize an amendment to the Merger Agreement or enter into a new merger agreement and proceed with a business combination. Clearday has informed us that the listing of our common stock on the Nasdaq would not be a condition to the closing of the merger. The parties are negotiating a new merger agreement (instead of an extension to the Merger Agreement) that would result in a similar all stock reverse acquisition of us. However, there is no assurance that the parties will complete such negotiation successfully or conclude the merger or any transaction at all.

Clearday has paid us $120,000 as a good faith, non-refundable, payment to provide us cash flow support as we negotiate a new merger agreement.

As discussed below, on February 26, 2021, we also obtained a Paycheck Protection Program loan of approximately $468,000. We believe these funds will be sufficient to conclude a merger with Clearday, if one can be negotiated and our shareholders approve the transaction by the third quarter of 2021. There is no assurance that this will occur and indeed there are significant risks that it will not occur.

If a merger is consummated with Clearday, of which there is no assurance, the merged company will focus on the development of Clearday’s non-residential daily care service model as well as the continued operation of Clearday’s existing Memory Care America residential memory care facilities. As part of plans to develop and expand its assortment of innovative, non-residential daily care services, Clearday intends to leverage our existing Cryogenic Cooler as an enabling technology for one of its service offerings in the healthcare market.

If a merger is not consummated with Clearday in the near future, we will likely be required to liquidate or declare bankruptcy, in which case there would likely be no payments or value for common stock holders.

2. Summary of Significant Accounting Policies

Basis of Presentation

We have incurred significant net losses since our inception and have an accumulated deficit of $332.5 million. In the three months ended April 3, 2021, we incurred a net loss of $569,000 and negative cash flows from operations of $453,000. In 2020, we incurred a net loss of $3.0 million and had negative cash flows from operations of $3.1 million. In 2020, we had an accumulated deficit of $331.9 million, a net loss of $9.2 million and negative cash flows from operations of $8.8 million. At December 31, 2020, we had $1.3 million in cash. Our cash resources may therefore not be sufficient to fund our business through the end of the current fiscal year. Therefore, unless we can successfully implement our strategic alternatives plan including, among others, a strategic investment financing which would allow us to pursue our current business plan, a business combination such as our merger with Clearday, or a sale of STI, we will need to raise additional capital during this fiscal year ending December 31, 2021 to maintain our viability. Additional financing may not be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. These factors raise substantial doubt about our ability to continue as a going concern.

Our plans regarding improving our future liquidity will require us to successfully implement our strategic plan to explore strategic alternatives focused on maximizing shareholder value. Strategic alternatives considered included, among others, a strategic investment financing which would allow the company to pursue its current business plan, a business combination such as a merger with another party, or a sale of STI. On January 28, 2020, we announced a cost reduction plan for the purpose of aligning our personnel needs and capital requirements as we explored strategic alternatives previously announced. We will maintain operations of our Sapphire Cryocooler cryogenics initiatives while ceasing additional manufacturing of our HTS Conductus® wire. The plan also included a 70% employee workforce reduction.

In 2019, we undertook steps to reduce our ongoing operating costs and we raised net cash proceeds of $3.9 million from the sale of our common and preferred shares and warrants.

On September 9, 2020, we effected a 1-for-10 reverse stock split of our common stock, or the 2020 Reverse Stock Split. As a result of the 2020 Reverse Stock Split, every ten shares of our pre-2020 Reverse Stock Split common stock were combined and reclassified into one share of our common stock. The 2020 Reverse Stock Split changed the authorized number of shares from 250,000,000 to 25,000,000. The par value of our common stock remained $0.001.

Share and per share data included in the Notes to Consolidated Financial Statements have been retroactively adjusted, as applicable, for the effect of the reverse stock splits. Certain of the information contained in the documents incorporated by reference herein and therein present information on our common stock on a pre-reverse stock split basis.

Principles of Consolidation

The interim condensed consolidated financial statements include the accounts of Superconductor Technologies Inc. and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated from the condensed consolidated financial statements.

Cash and Cash Equivalents

Cash and cash equivalents consist of highly liquid investments with original maturities of three months or less. Cash and cash equivalents are maintained with what we believe to be quality financial institutions and exceed FDIC limits. Historically, we have not experienced any losses due to such concentration of credit risk.

Accounts Receivable

We grant uncollateralized credit to our customers. We perform usual and customary credit evaluations of our customers before granting credit. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on historical write-off experience. Past due balances are reviewed for collectability. Accounts balances are charged off against the allowance when we deem it is probable the receivable will not be recovered. We do not have any off-balance sheet credit exposure related to our customers.

Revenue Recognition

On January 1, 2018, we adopted ASC Topic 606, Revenue from Contracts with Customers, and all of the related amendments (“ASC 606”) and applied it to all contracts. The adoption ASC topic 606 has had no effect to our consolidated financial statements.

Commercial and government contract revenues are recognized once all of the following conditions have been met: a) an authorized purchase order has been received in writing, b) the customer’s credit worthiness has been established, c) shipment of the product has occurred, d) title has transferred, and e) if stipulated by the contract, customer acceptance has occurred and all significant vendor obligations, if any, have been satisfied.

Government contract revenues are principally generated under research and development contracts. Revenues from research-related activities are derived from contracts with agencies of the U.S. Government. Credit risk related to accounts receivable arising from such contracts is considered minimal. All payments to us for work performed on contracts with agencies of the U.S. Government are subject to adjustment upon audit by the Defense Contract Audit Agency. Based on historical experience and review of our current project in process, we believe that adjustments from open audits will not have an effect on our financial position, results of operations or cash flows. We are using the expected cost-plus-margin approach as the suitable method for allocating transaction price to the performance obligations in the contract under ASC 606.

Shipping and Handling Fees and Costs

Shipping and handling fees billed to customers are included in net revenues. Shipping and handling fees associated with freight are generally included in cost of revenues.

Warranties

We offer warranties generally ranging from one to five years, depending on the product and negotiated terms of purchase agreements with our customers. Such warranties require us to repair or replace defective products returned to us during such warranty period at no cost to the customer. An estimate by us for warranty related costs is recorded by us at the time of sale based on our actual historical product return rates and expected repair costs. Such costs have been within our expectations.

Indemnities

In connection with the sales and manufacturing of our commercial products, we indemnify, without limit or term, our customers and contract manufacturers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to our products or other claims arising from our products. We cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under our indemnities because of the uncertainty as to whether a claim might arise and how much it might total. Historically, we have not incurred any expenses related to these indemnities.

Research and Development Costs

Research and development costs are charged to expense as incurred and include salary, facility, depreciation and material expenses. Research and development costs are charged to research and development expense.

Inventories

Inventories were stated at the lower of cost or net realizable value, with costs primarily determined using standard costs, which approximate actual costs utilizing the first-in, first-out method. We review inventory quantities on hand and on order and record, on a quarterly basis, a provision for excess and obsolete inventory and/or vendor cancellation charges related to purchase commitments. If the results of the review determine that a write-down is necessary, we recognize a loss in the period in which the loss is identified, whether or not the inventory is retained. Our April 3, 2021 and December 31, 2020 net inventory value was $68,000. During the three month period ending March 28, 2020 we ceased production of our Conductus wire and expensed the remaining $190,000 of wire inventory.

Preferred interest in real estate

We entered into a Securities Purchase Agreement with Clearday, which was consummated on July 6, 2020, pursuant to which we issued 400,000 shares of our common stock in exchange for a preferred interest in real estate we value at $1.6 million, implying a purchase price of $4.00 per share, based on the intraday stock trading price. The fair value of the real estate was based on the fact the building was acquired by Clearday in an arm’s-length all-cash purchase in November 2019 and a recent broker’s price report.

Property and Equipment

Property and equipment are recorded at cost. Equipment is depreciated using the straight-line method over their estimated useful lives ranging from three to five years. Leasehold improvements and assets financed under capital leases are amortized over the shorter of their useful lives or the lease term. Furniture and fixtures are depreciated over seven years. Expenditures for additions and major improvements are capitalized. Expenditures for minor tooling, repairs and maintenance and minor improvements are charged to expense as incurred. When property or equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts. Gains or losses from retirements and disposals are recorded in selling, general and administration expenses. During the three month period ending March 28, 2020 we ceased production of our Conductus wire and sold most of our production wire equipment for a gain of $510,000.

Patents, Licenses and Purchased Technology

Patents and licenses are recorded at cost and are amortized using the straight-line method over the shorter of their estimated useful lives or seventeen years. During the three month period ending March 28, 2020 we ceased production of our Conductus wire and sold many Conductus wire patents for no gain or loss and we also recognized a $134,000 impairment of other patents.

Other Assets and Investments

The realizability of long-lived assets is evaluated periodically as events or circumstances indicate a possible inability to recover the carrying amount. Long-lived assets that will no longer be used in the business are written off in the period identified since they will no longer be used in operations and generate any positive cash flows for us. Periodically, long-lived assets that will continue to be used by us will need to be evaluated for recoverability. Such evaluation is based on various analyses, including cash flow and profitability projections, as well as alternative uses, such as government contracts or awards. The analyses necessarily involve significant management judgment. In the event the projected undiscounted cash flows are less than net book value of the assets, the carrying value of the assets will be written down to their estimated fair value. We tested our long-lived assets at April 3, 2021 and none of our long-lived assets had book value.

Loss Contingencies

In the normal course of our business, we are subject to claims and litigation, including allegations of patent infringement. Liabilities relating to these claims are recorded when it is determined that a loss is probable and the amount of the loss can be reasonably estimated. Legal fees are recorded as services are provided. The costs of our defense in such matters are charged to operations as incurred. Insurance proceeds recoverable are recorded when deemed probable.

Income Taxes

We recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized. The guidance further clarifies the accounting for uncertainty in income taxes and sets a consistent framework to determine the appropriate level of tax reserve to maintain for uncertain tax positions. This interpretation uses a two-step approach wherein a tax benefit is recognized if a position is more-likely-than-not to be sustained. The amount of the benefit is then measured to be the highest tax benefit that is greater than 50% likely to be realized and sets out disclosure requirements to enhance transparency of our tax reserves. Unrecognized tax positions, if ever recognized in the condensed consolidated financial statements, are recorded in the statement of operations as part of the income tax provision. Our policy is to recognize interest and penalties accrued on uncertain tax positions, if any, as part of the income tax provision.

No liabilities for uncertain tax positions were recorded in the current year. No interest or penalties on uncertain tax positions have been expensed to date. We are not under examination by any taxing authorities. Our federal statute of limitations for examination of us is open for 2016 and subsequent filings.

As of December 31, 2020, we had net operating loss carryforwards for federal and state income tax purposes. We concluded that under the Internal Revenue Code change of control limitations, a maximum of $14.2 million of our $297.9 net operating loss carryforwards, which expire in the years 2021 through 2038, would be available for reduction of taxable income and reduced both the deferred tax asset and valuation allowance accordingly. Due to the uncertainty surrounding their realization, we recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying condensed consolidated balance sheets.

Marketing Costs

All costs related to marketing and advertising our products are charged to expense as incurred or at the time the advertising takes place. Advertising costs were not material in each of the quarters ended April 3, 2021 and March 28, 2020.

Net Loss Per Share

Basic and diluted net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding in each year. Net loss available to common stockholders is computed after deducting accumulated dividends on cumulative preferred stock, deemed dividends and accretion of redemption value on redeemable preferred stock for the period and beneficial conversion features on issuance of convertible preferred stock. Potential common shares are not included in the calculation of diluted loss per share because their effect is anti-dilutive.

Stock-based Compensation Expense

We grant both restricted stock awards and stock options to our key employees, directors and consultants. For the quarters ended April 3, 2021 and March 28, 2020, no options or awards were granted. The following table presents details of total stock-based compensation expense that is included in each functional line item on our condensed consolidated statements of operations:

	Three months ended
	April 3, 2021		March 28, 2020
Cost of commercial product revenues	$	-	$	1,000
Research and development		-		2,000
Selling, general and administrative		-		18,000
Total stock-based compensation expense	$	-	$	21,000

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The significant estimates in the preparation of the financial statements relate to the assessment of the carrying amount of accounts receivable, fixed assets, intangibles, estimated provisions for warranty costs, fair value of warrant derivatives, income taxes and disclosures related to litigation. Actual results could differ from those estimates and such differences may be material to the condensed consolidated financial statements.

Fair Value of Financial Instruments

We have estimated the fair value amounts of our financial instruments using the available market information and valuation methodologies considered appropriate. We determined the book value of our cash and cash equivalents, and other current liabilities according to their approximate fair value as of April 3, 2021.

Comprehensive Income

We have no items of other comprehensive income in any period and consequently have not included a Statement of Comprehensive Income.

Segment Information

We have historically operated in a single business segment: the research, development, manufacture and marketing of high performance products used in cellular base stations. We derived net commercial product revenues primarily from the sales of our AmpLink and SuperPlex products which we sold directly to wireless network operators in the United States. Net revenues derived principally from government contracts are presented separately on the consolidated statements of operations for all periods presented.

Certain Risks and Uncertainties

On January 28, 2020, we announced a cost reduction plan for the purpose of aligning our personnel needs and capital requirements as we explored strategic alternatives previously announced. We will maintain operations of our Sapphire Cryocooler cryogenics initiatives while ceasing additional manufacturing of our HTS Conductus® wire. The plan also included a 70% employee workforce reduction.

On February 26, 2020, we entered into a definitive merger agreement Clearday a privately-held company dedicated to delivering next generation longevity care and wellness services, whereby a wholly-owned subsidiary of STI will merge with and into Clearday in a stock-for-stock transaction with Clearday, with Clearday surviving and becoming a wholly-owned subsidiary of STI, which will then change its name to Clearday, Inc. See “Our Future Business” above for more information.

3. Stockholders’ Equity

The following is a summary of stockholders’ equity transactions for the three months ended April 3, 2021:

	Convertible								Capital in
	Preferred Stock				Common Stock				Excess of		Accumulated
	Shares		Amount		Shares		Amount		Par Value		Deficit			Total
Balance at December 31, 2020		328,925	$	-		3,151,780	$	3,000	$	334,632,000	$	(331,930,000	)	$	2,705,000
Merger partner contribution				-		-		-		120,000					120,000
Net loss												(569,000	)		(569,000	)
Balance at April 3, 2021		328,925	$	-		3,151,780	$	3,000	$	334,752,000	$	(332,499,000	)	$	2,256,000

The following is a summary of stockholders’ equity transactions for the three months ended March 28, 2020:

	Convertible								Capital in
	Preferred Stock				Common Stock				Excess of		Accumulated
	Shares		Amount		Shares		Amount		Par Value		Deficit			Total
Balance at December 31, 2019		328,925	$	-		1,773,189	$	2,000	$	330,474,000	$	(328,973,000	)	$	1,503,000
Warrant exercises				-		555,171		-		1,383,000					1,388,000
Stock-based compensation										21,000					21,000
Net loss												(1,079,000	)		(1,079,000	)
Balance at March 28, 2020		328,925	$	-		2,328,360	$	2,000	$	331,878,000	$	(330,052,000	)	$	1,833,000

Stock Options

At April 3, 2021, we had two active equity award option plans, the 2003 Equity Incentive Plan and the 2013 Equity Incentive Plan (collectively, the “Stock Option Plan”), although we can only grant new options under the 2013 Equity Incentive Plan. Under our Stock Option Plan, stock awards were made to our directors, key employees, consultants, and non-employee directors and consisted of stock options, restricted stock awards, performance awards, and performance share awards. Stock options were granted at prices no less than the market value on the date of grant. There were no stock option exercises during the three months ended April 3, 2021 or during the three months ended March 28, 2020.

The impact to the condensed consolidated statements of operations for the quarter ended April 3, 2021 on net loss was $0 and $0.00 on basic and diluted net loss per common share and for the quarter ended March 28, 2020 the impact was $20,000 and $0.01 on basic and diluted net loss per common share. No stock compensation cost was capitalized during either period. The total compensation cost related to nonvested awards not yet recognized was $0.

The following is a summary of stock option transactions under our Stock Option Plans at April 3, 2021:

	Number of Shares	Price Per Share		Weighted Average Exercise Price		Number of Options Exercisable		Weighted Average Exercise Price
Balance at December 31, 2020	7,863	$	19.20 - $ 28,440	$	255.90		7,863	$	255.90
Granted	-				-
Exercised	-				-
Canceled	12		28,440		28,440		12		28,440
Balance at April 3, 2021	7,851	$	19.20 - $ 26,280	$	211.24		7,851	$	211.24

The outstanding options expire on various dates through the end of October 2028. The weighted-average contractual term of options outstanding is 7.2 years and the weighted-average contractual term of stock options currently exercisable is 7.2 years. The exercise prices for these options range from $19.20 to $26,280 per share, for a total weight-average exercise price of $1.7 million. At April 3, 2021, no options had an exercise price less than the current market value.

Restricted Stock Awards

The grant date fair value of each share of our restricted stock awards is equal to the fair value of our common stock at the grant date. Shares of restricted stock under awards all have service conditions and vest over one to three years. There were no restricted stock award transactions during the three months ended April 3, 2021.

The impact to the condensed consolidated statements of operations for the three months ended April 3, 2020 was $0 and $0.00 on basic and diluted net loss per common share and for the quarter ended March 28, 2020 the impact was $1,000 and $0.00 on basic and diluted net loss per common share. No stock compensation cost was capitalized during the period. There was no total compensation cost related to nonvested awards not yet recognized at April 3, 2021.

Warrants

The following is a summary of outstanding warrants at April 3, 2021:

	Common Shares
	Total		Currently Exercisable		Price per Share		Expiration Date

Warrants related to August 2016 financing		5,350		5,350	$	300.00		February 2, 2022
Warrants related to August 2016 financing		500		500	$	385.50		August 2, 2021
Warrants related to December 2016 financing		68,567		68,567	$	200.00		December 14, 2021
Warrants related to March 2018 financing		15,810		15,810	$	114.00		September 9, 2023
Warrants related to March 2018 financing		1,107		1,107	$	158.00		March 6, 2023
Warrants related to July 2018 financing		257,143		257,143	$	35.00		July 25, 2023
Warrants related to July 2018 financing		15,428		15,428	$	43.75		July 25, 2023
Warrants related to May 2019 financing		11,900		11,900	$	12.50		May 23, 2024
Warrants related to October 2019 financing		217,200		217,200	$	2.50		October 10, 2024
Warrants related to October 2019 financing		30,916		30,916	$	3.13		October 8, 2024

On October 10, 2019 we completed a public offering of an aggregate of 1,183,400 shares of our common stock (or common stock equivalents) and warrants to purchase an aggregate of 1,183,400 shares of common stock with gross proceeds to us of approximately $3.0 million. The warrants are exercisable for five years at an exercise price equal to the public offering price. The offering was priced at $0.25 per share of common stock. The net proceeds to us from the offering, after deducting the placement agent fees and our estimated offering expenses, was approximately $2.4 million. The placement agent received warrants to purchase 82,838 shares of common stock, at an exercise price of $3.125, that will expire October 8, 2024 and are subject to a six month lock-up. In the quarter ended December 31, 2019, 39,528 of these warrants were exercised, providing us with proceeds of $99,000. In the quarter ended March 28, 2020, an additional 555,171 of these warrants were exercised, providing us with proceeds of $1.4 million.

On May 23, 2019 we completed a public offering of an aggregate of 170,000 shares of our common stock with gross proceeds to us of $1.7 million. The offering was priced at $10 per share of common stock. The net proceeds to us from the offering, after deducting the placement agent fees and our estimated offering expenses, was approximately $1.4 million. The placement agent received warrants to purchase 11,900 shares of common stock, at an exercise price of $1.25, that are subject to a nine month lock-up and will expire May 23, 2024.

Our warrants are exercisable by paying cash or, solely in the absence of an effective registration statement or prospectus, by cashless exercise for unregistered shares of common stock. The exercise price of the warrants is subject to standard antidilutive provision adjustment in the case of stock dividends or other distributions on shares of common stock or any other equity or equity equivalent securities payable in shares of common stock, stock splits, stock combinations, reclassifications or similar events affecting our common stock, and also, subject to limitations, upon any distribution of assets, including cash, stock or other property to our stockholders. The exercise price of the warrants is not subject to “price-based” anti-dilution adjustment. We have determined that these warrants related to issuance of common stock are subject to equity treatment because the warrant holder has no right to demand cash settlement and there are no unusual anti-dilution rights.

4. Loss Per Share

Basic and diluted net loss per share is based on the weighted-average number of common shares outstanding.

Since their impact would be anti-dilutive, our net loss per common share does not include the effect of the assumed exercise or vesting of the following shares:

	April 3, 2021		March 28, 2020

Outstanding stock options		7,851		12,141
Unvested restricted stock awards		-		33
Outstanding warrants		623,921		1,062,819
Total		631,772		1,074,993

Also, the preferred stock convertible into 182 shares of common stock was not included since its impact would be anti-dilutive.

5. Commitments and Contingencies

Operating Leases

We leased all of our properties. All of our operations, including our manufacturing facilities, comprising approximately 94,000 square feet, were located in an industrial complex in Austin, Texas that expired in March 31, 2020. We did not renew this lease as we ceased our Conductus wire manufacturing efforts to pursue our merger with Clearday. Our Austin lease contained a renewal option and also required us to pay utilities, insurance, taxes and other operating expenses.

For the three months ended April 3, 2021, operating lease expense was $0.

Patents and Licenses

We had entered into various licensing agreements requiring royalty payments ranging from 0.13% to 2.5% of specified product sales. Certain of these agreements contain provisions for the payment of guaranteed or minimum royalty amounts. In the event that we fail to pay any minimum annual royalties, these licenses may automatically be terminated. These royalty obligations terminate in 2026. Royalty expenses totaled $0 and $11,000 for the three months ended April 3, 2021 and March 28, 2020, respectively. Under the terms of certain royalty agreements, royalty payments made may be subject to audit. There have been no audits to date and we do not expect any possible future audit adjustments to be significant.

We have no minimum payments under operating leases and license obligations going forward.

6. Contractual Guarantees and Indemnities

During our normal course of business, we make certain contractual guarantees and indemnities pursuant to which we may be required to make future payments under specific circumstances. We have not recorded any liability for these contractual guarantees and indemnities in the accompanying condensed consolidated financial statements.

Warranties

We establish reserves for future product warranty costs that are expected to be incurred pursuant to specific warranty provisions with our customers. Our warranty reserves are established at the time of sale and updated throughout the warranty period based upon numerous factors including historical warranty return rates and expenses over various warranty periods.

Intellectual Property Indemnities

We indemnify certain customers and our contract manufacturers against liability arising from third-party claims of intellectual property rights infringement related to our products. These indemnities appear in development and supply agreements with our customers as well as manufacturing service agreements with our contract manufacturers, are not limited in amount or duration and generally survive the expiration of the contract. Given that the amount of potential liabilities related to such indemnities cannot be determined until an infringement claim has been made, we are unable to determine the maximum amount of losses that we could incur related to such indemnifications.

Director and Officer Indemnities and Contractual Guarantees

We have entered into indemnification agreements with our directors and executive officers which require us to indemnify such individuals to the fullest extent permitted by Delaware law. Our indemnification obligations under such agreements are not limited in amount or duration. Certain costs incurred in connection with such indemnities may be recovered under certain circumstances under various insurance policies. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit has been filed against a director or executive officer, we are unable to determine the maximum amount of losses that we could incur relating to such indemnities. Historically, any amounts payable pursuant to such director and officer indemnities have not had a material negative effect on our business, financial condition or results of operations.

We have also entered into severance and change in control agreements with certain of our executives. These agreements provide for the payment of specific compensation benefits to such executives upon the termination of their employment with us.

General Contractual Indemnities/Products Liability

During the normal course of business, we enter into contracts with customers where we agree to indemnify the other party for personal injury or property damage caused by our products. Our indemnification obligations under such agreements are not generally limited in amount or duration. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit has been filed, we are unable to determine the maximum amount of losses that we could incur relating to such indemnities. Historically, any amounts payable pursuant to such indemnities have not had a material negative effect on our business, financial condition or results of operations. We maintain general and product liability insurance as well as errors and omissions insurance which may provide a source of recovery to us in the event of an indemnification claim.

7. Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities

Paycheck Protection Program Loan

During March 2021, we received loan proceeds in the amount of $468,000 under the Paycheck Protection Program (the “PPP”) of the CARES Act, which was enacted March 27, 2020. The PPP loan is evidenced by a promissory note in favor of the Lender, which bears interest at the rate of 1.00% per annum. No payments of principal or interest are due under the note until the date on which the amount of loan forgiveness (if any) under the CARES Act, which can be up to 10 months after the end of the related notes covered period (which is defined as 24 weeks after the date of the loan) (the “Deferral Period”). The note may be prepaid at any time prior to maturity with no prepayment penalties. Funds from the PPP loan may be used only for payroll and related costs, costs used to continue group health care benefits, mortgage payments, rent, utilities, and interest on other debt obligations that were incurred prior to February 15, 2020 (the “Qualifying Expenses”). Under the terms of the PPP loan, certain amounts thereunder may be forgiven if they are used for Qualifying Expenses as described in and in compliance with the CARES Act. The Company utilized the PPP loan proceeds exclusively for Qualifying Expenses during the 24-week coverage period and will submit its application for forgiveness in accordance with the terms of the CARES Act and related guidance. In the event the PPP loan or any portion thereof is forgiven, the amount forgiven is applied to the outstanding principal.

To the extent, if any, that any or all of the PPP loan is not forgiven, beginning one month following expiration of the Deferral Period, and continuing monthly until 24 months from the date of each applicable Note (the “Maturity Date”), the Company is obligated to make monthly payments of principal and interest to the Lender with respect to any unforgiven portion of the Note, in such equal amounts required to fully amortize the principal amount outstanding on such Note as of the last day of the applicable Deferral Period by the applicable Maturity Date. The Company accounts for this loan on the balance sheet as financial liabilities reported as the long-term bank debt in the amount of $468,000.

Balance Sheet Data:

	April 3, 2021		December 31, 2020
Inventories:
Work In Process		68,000		68,000
	$	68,000	$	68,000

	April 3, 2021		December 31, 2020
Property and Equipment:
Equipment	$	316,000	$	316,000
		-
Less: accumulated depreciation and amortization		316,000		(316,000	)
	$	-	$	-

Depreciation expense amounted to $0 and $27,000 for the three month periods ended April 3, 2021 and March 28, 2020, respectively.

	April 3, 2021			December 31, 2020
Patents and Licenses:
Patents issued		278,000			278,000
Less accumulated amortization		(278,000	)		(278,000	)
Net patents issued		-			-
	$	-		$	-

Amortization expense related to these items totaled $0 and $11,000 for of the three month periods ended April 3, 2021 and March 28, 2020. No amortization expense is expected for the remainder of 2021, 2022 and 2023.

	April 3, 2021			December 31, 2020
Accrued Expenses and Other Long Term Liabilities:
Salaries Payable	$	30,000		$	10,000
Compensated absences		-			125,000
		30,000			135,000
Less current portion		(30,000	)		(135,000	)
Long term portion	$	-		$	-

	For the three months ended,
	April 3, 2021		March 28, 2020
Warranty Reserve Activity:
Beginning balance	$	-	$	8,000
Additions		-		-
Deductions		-		-
Ending balance	$	-	$	8,000

8. Subsequent Events

On May 14, 2021, the Company entered into an agreement and plan of merger with Allied Integral United, Inc. (known as “Clearday”) and a wholly-owned subsidiary of the Company. The agreement terminates the earlier merger agreement between the same parties, dated February 26, 2020, without liability. Subject to satisfaction of the conditions to closing of the merger, which include customary conditions and a minimum net working capital condition, the Company will issue common stock to the shareholders of Clearday such that, at the closing of the merger, the Company’s stockholders, and the Clearday stockholders would own, respectively, approximately 96.35% and 3.65% of the combined company’s outstanding shares. The merger agreement was approved by boards of directors of both companies and is subject to stockholder approval. Assuming satisfaction of conditions, the merger is expected to close in the third quarter of 2021. Clearday was incorporated on December 20, 2017 and commenced its business on December 31, 2018 when it acquired private funds that engaged in several businesses that have been conducted for the prior 15 years. Since December 2018, Clearday has been engaged in developing and providing the next generation of technology-enabled longevity care and wellness solutions, in alignment with the changing characteristics, expectations, and behaviors of the longevity consumer market.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

General

On February 26, 2020, we entered into a definitive merger agreement (with Allied Integral United, Inc. (“Clearday”), a privately-held company dedicated to delivering next generation longevity care and wellness services (the”Merger Agreement”), whereby our wholly-owned subsidiary will merge with and into Clearday in a stock-for-stock transaction with Clearday the “Merger”).

Results of Operations

Quarter Ended April 3, 2021 compared to the Quarter Ended March 28, 2020

We had $0 of revenue in the first quarter 2021. Total revenues decreased from $184,000 in the first quarter of 2020 to $0 in the first quarter of 2021. As noted above in “Our Future Business” we ceased work on additional manufacturing of our HTS Conductus wire. Commercial product revenues and government contract revenues are expected to remain near zero as we pursue our announced merger agreement.

Cost of revenues includes all direct costs, manufacturing overhead, preproduction process development and provision for excess and obsolete inventories. The cost of revenues decreased to $0 in the first quarter of 2021 compared to $190,000 for the first quarter of 2020. Our cost of revenues includes both variable and fixed cost components. The variable component consists primarily of materials, assembly and test labor, overhead, which includes utilities, transportation costs and warranty costs. The fixed component includes equipment and leasehold depreciation, purchasing expenses and quality assurance costs. As a result, our gross profit margins decrease as revenue and production volumes decline due to lower sales volume and higher amounts of production overhead variances expensed to cost of sales; and our gross profit margins increase as our revenue and production volumes increase due to higher sales volume and lower amounts of production overhead variances expensed to cost of sales.

The following is an analysis of our product gross loss:

	For the quarters ended
	April 3, 2021		March 28 2020
	(Dollars in thousands)
Commercial product revenues	$	-	$	10
Cost of commercial product revenues		-		190
Gross loss	$	-	$	(180	)

We had no commercial revenue and no cost of commercial cost of revenue and, therefore, no gross profit in the first quarter of 2021 from manufacturing of our commercial products compared to a gross loss of $180,000 in the first quarter of 2020. Our first quarter 2021 gross loss decreased due to our discontinued efforts to produce Conductus wire.

In June 2017, we finalized negotiations on a $4.5 million DOE contract and began work on this government contract. Funding for the second phase of this contact had been delayed until late 2019. Our first quarter 2021 government contract revenues were $0 and cost of government contract revenues was $0, compared to $174,000 and $71,000, respectively, in the first quarter of 2020. Since we have ceased manufacturing of our Conductus wire, we have now concluded our efforts on this contract.

Research and development expenses related to development of new Conductus wire products and new wire products manufacturing processes. Total expenses totaled $0 and $178,000, in the first quarters of 2021 and 2020, respectively. Our 2021 expenses decreased to $0 as we ceased these efforts at the end of January 2020 when we stopped work on our Conductus wire.

Selling, general and administrative expenses were $569,000 and $825,000, in the first quarters of 2021 and 2020, respectively. These expenses were lower in the first quarter of 2021 compared with the first quarter of 2020 principally due to our previously announced cost reduction plan and our reduced operations as we pursue our merger with Clearday.

Other income of $0 and $1,000 in the first quarters of 2021 and 2020, respectively, was from interest income.

We had a net loss of $569,000 and $1.1 million for quarters ended April 3, 2021 and March 28, 2020, respectively. The net loss available to common stockholders totaled $0.18 per common share in the first quarter of 2021, compared to a net loss of $0.56 per common share in the first quarter of 2020. The per share loss in 2021 is lower due to our terminated wire manufacturing efforts, our cost reduction plan and the increased number of common shares outstanding at April 3, 2021 compared to March 28, 2020.

Liquidity and Capital Resources

Cash Flow Analysis

As of April 3, 2021, we had working capital of $1.1 million, including $1.3 million in cash and cash equivalents, compared to working capital of $1.1 million at December 31, 2020, which included $1.3 million in cash and cash equivalents. We currently invest our excess cash in short-term, investment-grade, money-market instruments with maturities of three months or less.

Cash and cash equivalents was $1.3 million at April 3, 2021 and December 31, 2019.

Cash used in operations totaled $453,000 in the first quarter of 2021. This amount was used to fund the cash portion of our net loss with virtually no changes in our working capital.

No cash was used in or provided by investing activities in the three months ended April 3, 2021.

In the three months ended April 3, 2021, we received loan proceeds in the amount of $468,000 under the Paycheck Protection Program (the “PPP”) of the CARES Act, which was enacted March 27, 2020.

Contractual Obligations and Commercial Commitments

We leased all of our properties. All of our leases expired or were terminated in March 2020. All of our operations were located in Austin, Texas.

We have not had other material changes outside of the ordinary course of business in our contractual obligations as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

Capital Expenditures

We made no investments for fixed assets in the first quarter of 2021 and we do not expect to make capital expenditures during the remainder of 2021.

Future Liquidity

For the quarter ended April 3, 2021, we incurred a net loss of $569,000 and had negative cash flows from operations of $453,000. In the full 2020 year, we incurred a net loss of $3 million and had negative cash flows from operations of $3.1 million.

Clearday made a good faith payment to us of $120,000 in early February 2021, which is non-refundable, to assist with our operating expenses as we negotiate a new merger agreement.

On February 26, 2021, we entered into an unsecured note evidencing our loan under the Paycheck Protection Program (the “PPP Loan”) in the principal amount of approximately $468,000. Proceeds of our PPP Loan may be used for payroll costs, costs related to certain group health care benefits, rent payments, utility payments, mortgage interest payments, interest payments on other debt obligations. Our current plans are to seek partial loan forgiveness in the amount of approximately $150,000, as permitted under the PPP Loan, and to repay the remainder.

Our cash resources are not sufficient to fund our business through the end of the current fiscal year, however, we believe they are sufficient to fund our operations through approximately August 2021, during which time we intend to pursue merger negotiations and, if they are successful, shareholder approval for a merger with Clearday. There is no assurance that these negotiations will be successful or that shareholder approval will be obtained, in which case we likely will need to seek bankruptcy protection. These factors raise substantial doubt about our ability to continue as a going concern.

Net Operating Loss Carryforward

As of December 31, 2020, we had net operating loss carryforwards for federal and state income tax purposes. We concluded that under the Internal Revenue Code change of control limitations, a maximum of $14.2 million of our $297.4 million net operating loss carryforwards would be available for reduction of taxable income and reduced both the deferred tax asset and valuation allowance accordingly. Due to the uncertainty surrounding their realization, we recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying condensed consolidated balance sheets.

Critical Accounting Policies and Estimates

Our discussion and analysis of our historical financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these condensed consolidated financial statements in conformity with those principles requires us to make estimates of certain items and judgments as to certain future events including for example those related to bad debts, inventories, recovery of long-lived assets (including intangible assets), income taxes, warranty obligations, and contingencies. These determinations, even though inherently subjective and subject to change, affect the reported amounts of our assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. While we believe that our estimates are based on reasonable assumptions and judgments at the time they are made, some of our assumptions, estimates and judgments will inevitably prove to be incorrect. As a result, actual outcomes will likely differ from our accruals, and those differences—positive or negative—could be material. Some of our accruals are subject to adjustment, as we believe appropriate, based on revised estimates and reconciliation to the actual results when available

In addition, we identified certain critical accounting policies which affect certain of our more significant estimates and assumptions used in preparing our condensed consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020. We have not made any material changes to our other policies.

Backlog

Our commercial backlog consisted of accepted product purchase orders with scheduled delivery dates during the next twelve months. We had no commercial backlog at April 3, 2021 and at December 31, 2020.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We do not believe that there was a material change in our exposure to market risk at April 3, 2021 compared with our market risk exposure on December 31, 2020. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Market Risk” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.

Item 4. Controls and Procedures

We have established disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). As of the end of the period covered by this report we carried out an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 of the Securities and Exchange Act of 1934, as amended. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective.

There were no changes in our internal controls over financial reporting during the quarter ended April 3, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

We do not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

PART II
OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we are party to various lawsuits, claims and other legal proceedings that arise in the ordinary course of our business. Excluding ordinary, routine litigation incidental to our business, we are not currently a party to any legal proceedings that we believe would reasonably be expected to have a material adverse effect on our business, financial condition or results of operation or cash flow.

Item 1A. Risk Factors

A description of the risk factors associated with our business is contained in Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 filed with the Securities and Exchange Commission on March 31, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

Item 6. Exhibits.

	Number		Description of Document

	31.1		Statement of CEO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
	31.2		Statement of CFO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
	32.1		Statement of CEO Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
	32.2		Statement of CFO Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
	101.INS		XBRL Instance Document*
	101.SCH		XBRL Taxonomy Extension Schema Document*
	101.CAL		XBRL Calculation Linkbase Document*
	101.DEF		XBRL Taxonomy Extension Definition Linkbase Document*
	101.LAB		XBRL Label Linkbase Document*
	101.PRE		XBRL Taxonomy Presentation Linkbase Document*

* Filed herewith.

** Furnished, not filed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on our behalf by the undersigned thereunto duly authorized.

	SUPERCONDUCTOR TECHNOLOGIES INC.

Dated: May 18, 2021	/s/ William J. Buchanan
	William J. Buchanan
	Chief Financial Officer

	/s/ Jeffrey A. Quiram
	Jeffrey A. Quiram
	President and Chief Executive Officer

EX-31.1 2 ex31-1.htm

EXHIBIT 31.1

Statement Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by

Principal Executive Officer

Regarding Facts and Circumstances Relating to Exchange Act Filings

I, Jeffrey A. Quiram, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Superconductor Technologies Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 18, 2021

	/s/ Jeffrey A. Quiram
	Jeffrey A. Quiram
	President and Chief Executive Officer

EX-31.2 3 ex31-2.htm

EXHIBIT 31.2

Statement Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 by

Principal Financial Officer

Regarding Facts and Circumstances Relating to Exchange Act Filings

I, William J. Buchanan, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Superconductor Technologies Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 18, 2021

	/s/ William J. Buchanan
	William J. Buchanan
	Chief Financial Officer

EX-32.1 4 ex32-1.htm

EXHIBIT 32.1

Statement Pursuant to Section 906 the Sarbanes-Oxley Act of 2002

Principal Executive Officer

Regarding Facts and Circumstances Relating to Exchange Act Filings

Dated: May 18, 2021

I, Jeffrey A. Quiram, Chief Executive Officer of Superconductor Technologies Inc., hereby certify, to my knowledge, that:

1. the accompanying Quarterly Report on Form 10-Q of Superconductor Technologies for the three month period ended April 3, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities and Exchange Act of 1934, as amended; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Superconductor Technologies Inc.

IN WITNESS WHEREOF, the undersigned has executed this Statement as of the date first written above.

	/s/ Jeffrey A. Quiram
	Jeffrey A. Quiram
	President and Chief Executive Officer

EX-32.2 5 ex32-2.htm

EXHIBIT 32.2

Statement Pursuant to Section 906 the Sarbanes-Oxley Act of 2002

Principal Financial Officer

Regarding Facts and Circumstances Relating to Exchange Act Filings

Dated: May 18, 2021

I, William J. Buchanan, Chief Financial Officer of Superconductor Technologies Inc., hereby certify, to my knowledge, that:

1. the accompanying Quarterly Report on Form 10-Q of Superconductor Technologies for the period ended April 3, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities and Exchange Act of 1934, as amended; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Superconductor Technologies Inc.

	/s/ William J. Buchanan
	William J. Buchanan
	Chief Financial Officer

EX-101.INS 6 scon-20210403.xml XBRL INSTANCE FILE 0000895665 2021-01-04 2021-04-03 0000895665 2019-12-31 0000895665 us-gaap:CommonStockMember 2019-12-31 0000895665 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000895665 us-gaap:RetainedEarningsMember 2019-12-31 0000895665 2020-12-31 0000895665 2019-01-01 2019-12-31 0000895665 2020-09-08 2020-09-09 0000895665 2020-09-09 0000895665 2020-07-05 2020-07-06 0000895665 2020-07-06 0000895665 scon:PatentsAndLicensesMember 2020-01-01 2020-12-31 0000895665 us-gaap:CommonStockMember 2019-10-09 2019-10-10 0000895665 us-gaap:CommonStockMember 2019-10-10 0000895665 us-gaap:CommonStockMember us-gaap:IPOMember 2019-05-22 2019-05-23 0000895665 us-gaap:CommonStockMember us-gaap:IPOMember 2019-05-23 0000895665 us-gaap:WarrantMember 2019-10-10 0000895665 us-gaap:WarrantMember 2019-10-01 2019-12-31 0000895665 scon:PlacementAgentWarrantMember 2019-05-23 0000895665 scon:WarrantSixMember 2021-04-03 0000895665 scon:WarrantOneMember 2021-04-03 0000895665 scon:WarrantTwoMember 2021-04-03 0000895665 scon:WarrantThreeMember 2021-04-03 0000895665 scon:WarrantFourMember 2021-04-03 0000895665 scon:WarrantFiveMember 2021-04-03 0000895665 scon:WarrantSevenMember 2021-04-03 0000895665 scon:WarrantEightMember 2021-04-03 0000895665 scon:WarrantNineMember 2021-04-03 0000895665 scon:WarrantTenMember 2021-04-03 0000895665 scon:AustinTexasMember 2021-01-04 2021-04-03 0000895665 scon:AustinTexasMember 2021-04-03 0000895665 scon:OutstandingStockOptionsMember 2021-01-04 2021-04-03 0000895665 scon:OutstandingStockOptionsMember 2020-01-01 2020-03-28 0000895665 scon:UnvestedRestrictedStockAwardsMember 2021-01-04 2021-04-03 0000895665 scon:UnvestedRestrictedStockAwardsMember 2020-01-01 2020-03-28 0000895665 scon:OutstandingWarrantsMember 2021-01-04 2021-04-03 0000895665 scon:OutstandingWarrantsMember 2020-01-01 2020-03-28 0000895665 us-gaap:EquipmentMember 2020-12-31 0000895665 us-gaap:PatentedTechnologyMember 2020-12-31 0000895665 us-gaap:ConvertiblePreferredStockMember 2019-12-31 0000895665 2020-09-10 0000895665 2021-05-11 0000895665 us-gaap:ProductMember 2021-01-04 2021-04-03 0000895665 us-gaap:GovernmentContractMember 2021-01-04 2021-04-03 0000895665 us-gaap:ProductMember 2020-01-01 2020-03-28 0000895665 us-gaap:GovernmentContractMember 2020-01-01 2020-03-28 0000895665 2020-01-01 2020-03-28 0000895665 2021-04-03 0000895665 2020-03-28 0000895665 scon:EmployeeMember 2020-01-28 0000895665 2020-01-27 2020-01-28 0000895665 scon:CleardayIncMember scon:NewMergerAgreementMember 2020-02-25 2020-02-26 0000895665 scon:CleardayIncMember scon:NewMergerAgreementMember scon:PaycheckProtectionProgramLoanMember 2021-02-25 2021-02-26 0000895665 us-gaap:CostOfSalesMember 2021-01-04 2021-04-03 0000895665 us-gaap:CostOfSalesMember 2020-01-01 2020-03-28 0000895665 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-04 2021-04-03 0000895665 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-03-28 0000895665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-01-04 2021-04-03 0000895665 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-28 0000895665 2020-01-01 2020-12-31 0000895665 srt:MaximumMember 2020-12-31 0000895665 us-gaap:StockOptionMember scon:StockOptionPlansMember 2021-01-04 2021-04-03 0000895665 us-gaap:StockOptionMember scon:StockOptionPlansMember srt:MinimumMember 2021-01-04 2021-04-03 0000895665 us-gaap:StockOptionMember scon:StockOptionPlansMember srt:MaximumMember 2021-01-04 2021-04-03 0000895665 us-gaap:StockOptionMember scon:StockOptionPlansMember 2021-04-03 0000895665 us-gaap:StockOptionMember scon:StockOptionPlansMember srt:MinimumMember 2021-04-03 0000895665 us-gaap:StockOptionMember scon:StockOptionPlansMember srt:MaximumMember 2021-04-03 0000895665 us-gaap:ConvertiblePreferredStockMember 2021-01-04 2021-04-03 0000895665 us-gaap:ConvertiblePreferredStockMember 2020-01-01 2020-03-28 0000895665 us-gaap:CommonStockMember 2021-01-04 2021-04-03 0000895665 us-gaap:CommonStockMember 2020-01-01 2020-03-28 0000895665 us-gaap:AdditionalPaidInCapitalMember 2021-01-04 2021-04-03 0000895665 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-28 0000895665 us-gaap:RetainedEarningsMember 2021-01-04 2021-04-03 0000895665 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-28 0000895665 us-gaap:ConvertiblePreferredStockMember 2021-04-03 0000895665 us-gaap:CommonStockMember 2021-04-03 0000895665 us-gaap:AdditionalPaidInCapitalMember 2021-04-03 0000895665 us-gaap:RetainedEarningsMember 2021-04-03 0000895665 us-gaap:ConvertiblePreferredStockMember 2020-03-28 0000895665 us-gaap:CommonStockMember 2020-03-28 0000895665 us-gaap:AdditionalPaidInCapitalMember 2020-03-28 0000895665 us-gaap:RetainedEarningsMember 2020-03-28 0000895665 us-gaap:LicensingAgreementsMember srt:MinimumMember 2021-01-04 2021-04-03 0000895665 us-gaap:LicensingAgreementsMember srt:MaximumMember 2021-01-04 2021-04-03 0000895665 us-gaap:EquipmentMember 2021-04-03 0000895665 us-gaap:PatentedTechnologyMember 2021-04-03 0000895665 us-gaap:SubsequentEventMember scon:MergerAgreementMember scon:CompanysStockholdersMember 2021-05-14 0000895665 us-gaap:SubsequentEventMember scon:MergerAgreementMember scon:CleardayStockholdersMember 2021-05-14 0000895665 us-gaap:SubsequentEventMember scon:MergerAgreementMember scon:CleardayIncMember 2021-05-13 2021-05-14 0000895665 scon:PaycheckProtectionProgramLoanMember scon:CARESActMember 2021-03-01 2021-03-31 0000895665 scon:PaycheckProtectionProgramLoanMember scon:CARESActMember 2021-03-31 0000895665 us-gaap:WarrantMember 2020-01-01 2020-03-28 0000895665 scon:RestrictedStockAwardsMember 2021-01-04 2021-04-03 0000895665 scon:StockOptionsMember 2021-01-04 2021-04-03 0000895665 scon:RestrictedStockAwardsMember 2020-01-01 2020-03-28 0000895665 scon:StockOptionsMember 2020-01-01 2020-03-28 0000895665 scon:StockOptionsMember srt:MinimumMember 2021-01-04 2021-04-03 0000895665 scon:StockOptionsMember srt:MaximumMember 2021-01-04 2021-04-03 0000895665 scon:StockOptionsMember 2021-04-03 iso4217:USD xbrli:shares xbrli:pure utr:sqft iso4217:USD xbrli:shares

10000

174000

184000

190000

71000

569000

825000

569000

1264000

-569000

-1080000

1000

3151780

1927279

180000

224000

135000

30000

3020000

2978000

1420000

1378000

1276000

1291000

3000

68000

315000

722000

3020000

2978000

315000

254000

76000

19000

-331930000

-332499000

15000

1130000

38000

124000

-5000

57000

58000

468000

1388000

1212000

-453000

-8803000

-1470000

-3138000

2400000

1400000

21000

2000000

328925

25000000

250000000

25000000

3151780

Q1 0000895665 --12-31

99000

1388000

1400000

false true false false Non-accelerated Filer

0.001

2021 10-Q 2021-04-03 SUPERCONDUCTOR TECHNOLOGIES INC Yes Yes 3151780

1600000

510000

134000

190000

1212000

1183400

170000

-569000

-9229000

-1079000

-2957000

-569000

-1079000

1-for-10 reverse stock split

3900000

134000

400000

1600000

4.00

0.50

21000

1000

2000

18000

2979000

14200000

1183400

82838

11900

3000000 1700000

0.25

10.00

P5Y

3.125

12.50

35.00

300.00

385.50

200.00

114.00

158.00

43.75

12.50

2.50

3.13

P7Y2M12D

7851

39528 555171

2024-10-08

2024-05-23

2023-07-25

2022-02-02

2021-08-02

2021-12-14

2023-09-09

2023-03-06

2023-07-25

2024-05-23

2024-10-10

2024-10-08

211.24

19.20

26280

257143

5350

500

68567

15810

1107

15428

11900

217200

30916

257143 5350 500 68567 15810 1107 15428 11900 217200 30916

94000

2020-03-31

0.0013 0.025

11000

182

631772

7851

12141

623921

1062819

1074993

68000

316000

278000

8000

125000

10000

30000

135000

30000

-135000 -30000

-0.18

-0.56

178000

1503000

2000

330474000

-328973000

2705000

2256000

1833000

3000

334752000

-332499000

2000

331878000

-330052000

1773189

328925

3151780

328925

2328360

173000

-87000

713000

1291000

1843000

468000

1.General   Please see “Our Future Business” below regarding material information and updates that in many material respects superseded and modify the following general business description.   Superconductor Technologies Inc (“STI”) was a leading company in developing and commercializing high temperature superconductor (“HTS”) materials and related technologies. Superconductivity is the unique ability to conduct electricity with little or no resistance when cooled to “critical” temperatures. HTS materials are a family of elements that demonstrate superconducting properties at temperatures significantly warmer than previous superconducting materials. Electric currents that flow through conventional conductors encounter resistance. This resistance requires power to overcome and generates heat. HTS materials can substantially improve the performance characteristics of electrical systems, reduce power loss, and lower heat generation providing extremely high current carrying density and zero resistance to direct current.   We were established in 1987 shortly after the discovery of HTS materials. Our stated objective was to develop products based on these materials for the commercial marketplace.   After analyzing the market opportunities available, we decided to develop products for the utility and telecommunications industries.   Our initial product was completed in 1998 and we began delivery to a number of wireless network providers. In the following 13 years, we continued to refine and improve the platform, with the primary focus on improving reliability, increasing performance and runtime, and most importantly, removing cost from the manufacturing process of the required subsystems. Our cost reducing efforts led to the invention of our proprietary, high-yield and high throughput HTS material deposition manufacturing process.   In early 2018, we announced the concentration of our future HTS Conductus® wire product development efforts on NGEM to capitalize on several accelerating energy megatrends. This refined focus is very synergistic with our program with the Department of Energy (DOE) award for the development of superconducting wire to enable NGEM.   On January 28, 2020, we announced a cost reduction plan for the purpose of aligning our personnel needs and capital requirements as we explored strategic alternatives previously announced. We have maintained operations of our Sapphire Cryocooler cryogenics initiatives while ceasing additional manufacturing of our HTS Conductus wire. The plan also included a 70% employee workforce reduction.   Subsequent to the announcement on January 28, 2020 about our cost reduction plan, we started the process of selling, in separate transactions, assets that we deemed non-essential going forward. The latest such transaction entered into on March 5, 2020, when considered in combination with the prior transactions since January 28, 2020, may be deemed a material definitive purchase agreement for sales of various production, R&D, and testing equipment and selected intellectual property related primarily to our superconducting wire initiative. The aggregate sales prices of the post January 28th transactions was approximately $1,075,000, all sold to purchasers having no affiliation with us.   As a result of these sales, we no longer have the ability to resume HTS wire operations without significant new investments and restructured operations and a new HTS wire business plan, neither of which we currently intend to pursue, as we instead focus our efforts on completing the Merger (as defined below).   Our Future Business   On February 26, 2020, we entered into a definitive merger agreement with Allied Integral United, Inc. (which will change its name to, and is therefore referred herein as, “Clearday”), a privately-held company dedicated to delivering next generation longevity care and wellness services, whereby our wholly-owned subsidiary will merge with and into Clearday in a stock-for-stock transaction with Clearday (the “Merger”), with Clearday surviving and becoming our wholly-owned subsidiary, we will then change our name to Clearday, Inc (the “Merger Agreement”).   As previously disclosed, on May 12, 2020, the Merger Agreement was amended by the parties to (i) add a covenant that the parties shall use their commercially reasonable efforts to cause STI to at all times remain listed on the Nasdaq Capital Market (or higher tier) and that if STI ceases to be listed on the Nasdaq Capital Market then the parties shall (including after the closing of the Merger) use their commercially reasonable efforts to cause STI to become listed on either the Nasdaq Capital Market or the NYSE MKT as promptly as reasonably possible, (ii) remove the conditions to closing the Merger that Nasdaq must determine that all listing deficiencies have been cured and determine to approve the listing of STI’s common stock on the Nasdaq and remove any other provisions in the Merger Agreement of like effect, (iii) extend the “outside date” for the Merger to close until the close of business on September 21, 2020 and (iv) require a customary tax representation letter from STI as a closing condition   As previously disclosed, due to our failure to comply with its listing conditions, the Nasdaq Stock Market notified us that it intended to complete the delisting of our common stock by filing a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission, which it did on February 2, 2021. Our common stock is no longer listed on a National Securities Exchange. Our stock trades on the OTC QB Market.   As also previously disclosed, we announced that, although the “outside date” of our Merger Agreement with Clearday has expired, both the Company and Clearday intended to finalize an amendment to the Merger Agreement or enter into a new merger agreement and proceed with a business combination. Clearday has informed us that the listing of our common stock on the Nasdaq would not be a condition to the closing of the merger. The parties are negotiating a new merger agreement (instead of an extension to the Merger Agreement) that would result in a similar all stock reverse acquisition of us. However, there is no assurance that the parties will complete such negotiation successfully or conclude the merger or any transaction at all.   Clearday has paid us $120,000 as a good faith, non-refundable, payment to provide us cash flow support as we negotiate a new merger agreement.   As discussed below, on February 26, 2021, we also obtained a Paycheck Protection Program loan of approximately $468,000. We believe these funds will be sufficient to conclude a merger with Clearday, if one can be negotiated and our shareholders approve the transaction by the third quarter of 2021. There is no assurance that this will occur and indeed there are significant risks that it will not occur.   If a merger is consummated with Clearday, of which there is no assurance, the merged company will focus on the development of Clearday’s non-residential daily care service model as well as the continued operation of Clearday’s existing Memory Care America residential memory care facilities. As part of plans to develop and expand its assortment of innovative, non-residential daily care services, Clearday intends to leverage our existing Cryogenic Cooler as an enabling technology for one of its service offerings in the healthcare market.   If a merger is not consummated with Clearday in the near future, we will likely be required to liquidate or declare bankruptcy, in which case there would likely be no payments or value for common stock holders.

4. Loss Per Share   Basic and diluted net loss per share is based on the weighted-average number of common shares outstanding.   Since their impact would be anti-dilutive, our net loss per common share does not include the effect of the assumed exercise or vesting of the following shares:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 28, 2020</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%">Outstanding stock options</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: right">7,851</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: right">12,141</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Unvested restricted stock awards</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">33</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Outstanding warrants</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">623,921</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,062,819</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">631,772</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">1,074,993</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   Also, the preferred stock convertible into 182 shares of common stock was not included since its impact would be anti-dilutive.

6. Contractual Guarantees and Indemnities   During our normal course of business, we make certain contractual guarantees and indemnities pursuant to which we may be required to make future payments under specific circumstances. We have not recorded any liability for these contractual guarantees and indemnities in the accompanying condensed consolidated financial statements.   Warranties   We establish reserves for future product warranty costs that are expected to be incurred pursuant to specific warranty provisions with our customers. Our warranty reserves are established at the time of sale and updated throughout the warranty period based upon numerous factors including historical warranty return rates and expenses over various warranty periods.   Intellectual Property Indemnities   We indemnify certain customers and our contract manufacturers against liability arising from third-party claims of intellectual property rights infringement related to our products. These indemnities appear in development and supply agreements with our customers as well as manufacturing service agreements with our contract manufacturers, are not limited in amount or duration and generally survive the expiration of the contract. Given that the amount of potential liabilities related to such indemnities cannot be determined until an infringement claim has been made, we are unable to determine the maximum amount of losses that we could incur related to such indemnifications.   Director and Officer Indemnities and Contractual Guarantees   We have entered into indemnification agreements with our directors and executive officers which require us to indemnify such individuals to the fullest extent permitted by Delaware law. Our indemnification obligations under such agreements are not limited in amount or duration. Certain costs incurred in connection with such indemnities may be recovered under certain circumstances under various insurance policies. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit has been filed against a director or executive officer, we are unable to determine the maximum amount of losses that we could incur relating to such indemnities. Historically, any amounts payable pursuant to such director and officer indemnities have not had a material negative effect on our business, financial condition or results of operations.   We have also entered into severance and change in control agreements with certain of our executives. These agreements provide for the payment of specific compensation benefits to such executives upon the termination of their employment with us.   General Contractual Indemnities/Products Liability   During the normal course of business, we enter into contracts with customers where we agree to indemnify the other party for personal injury or property damage caused by our products. Our indemnification obligations under such agreements are not generally limited in amount or duration. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit has been filed, we are unable to determine the maximum amount of losses that we could incur relating to such indemnities. Historically, any amounts payable pursuant to such indemnities have not had a material negative effect on our business, financial condition or results of operations. We maintain general and product liability insurance as well as errors and omissions insurance which may provide a source of recovery to us in the event of an indemnification claim.

5. Commitments and Contingencies   Operating Leases   We leased all of our properties. All of our operations, including our manufacturing facilities, comprising approximately 94,000 square feet, were located in an industrial complex in Austin, Texas that expired in March 31, 2020. We did not renew this lease as we ceased our Conductus wire manufacturing efforts to pursue our merger with Clearday. Our Austin lease contained a renewal option and also required us to pay utilities, insurance, taxes and other operating expenses.   For the three months ended April 3, 2021, operating lease expense was $0.   Patents and Licenses   We had entered into various licensing agreements requiring royalty payments ranging from 0.13% to 2.5% of specified product sales. Certain of these agreements contain provisions for the payment of guaranteed or minimum royalty amounts. In the event that we fail to pay any minimum annual royalties, these licenses may automatically be terminated. These royalty obligations terminate in 2026. Royalty expenses totaled $0 and $11,000 for the three months ended April 3, 2021 and March 28, 2020, respectively. Under the terms of certain royalty agreements, royalty payments made may be subject to audit. There have been no audits to date and we do not expect any possible future audit adjustments to be significant.   We have no minimum payments under operating leases and license obligations going forward.

7. Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities   Paycheck Protection Program Loan   During March 2021, we received loan proceeds in the amount of $468,000 under the Paycheck Protection Program (the “PPP”) of the CARES Act, which was enacted March 27, 2020. The PPP loan is evidenced by a promissory note in favor of the Lender, which bears interest at the rate of 1.00% per annum. No payments of principal or interest are due under the note until the date on which the amount of loan forgiveness (if any) under the CARES Act, which can be up to 10 months after the end of the related notes covered period (which is defined as 24 weeks after the date of the loan) (the “Deferral Period”). The note may be prepaid at any time prior to maturity with no prepayment penalties. Funds from the PPP loan may be used only for payroll and related costs, costs used to continue group health care benefits, mortgage payments, rent, utilities, and interest on other debt obligations that were incurred prior to February 15, 2020 (the “Qualifying Expenses”). Under the terms of the PPP loan, certain amounts thereunder may be forgiven if they are used for Qualifying Expenses as described in and in compliance with the CARES Act. The Company utilized the PPP loan proceeds exclusively for Qualifying Expenses during the 24-week coverage period and will submit its application for forgiveness in accordance with the terms of the CARES Act and related guidance. In the event the PPP loan or any portion thereof is forgiven, the amount forgiven is applied to the outstanding principal.   To the extent, if any, that any or all of the PPP loan is not forgiven, beginning one month following expiration of the Deferral Period, and continuing monthly until 24 months from the date of each applicable Note (the “Maturity Date”), the Company is obligated to make monthly payments of principal and interest to the Lender with respect to any unforgiven portion of the Note, in such equal amounts required to fully amortize the principal amount outstanding on such Note as of the last day of the applicable Deferral Period by the applicable Maturity Date. The Company accounts for this loan on the balance sheet as financial liabilities reported as the long-term bank debt in the amount of $468,000.   Balance Sheet Data:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; text-align: justify">Inventories:</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Work In Process</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right">68,000</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right">68,000</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">68,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">68,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Property and Equipment:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Equipment</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%">$</td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right">316,000</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%">$</td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right">316,000</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Less: accumulated depreciation and amortization</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">316,000</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(316,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   Depreciation expense amounted to $0 and $27,000 for the three month periods ended April 3, 2021 and March 28, 2020, respectively.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Patents and Licenses:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt; text-align: justify">Patents issued</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">278,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">278,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Less accumulated amortization</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(278,000</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(278,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Net patents issued</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   Amortization expense related to these items totaled $0 and $11,000 for of the three month periods ended April 3, 2021 and March 28, 2020. No amortization expense is expected for the remainder of 2021, 2022 and 2023.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Accrued Expenses and Other Long Term Liabilities:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt; text-align: justify">Salaries Payable</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">30,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">10,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Compensated absences</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">125,000</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td> </td> <td style="text-align: right">30,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">135,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Less current portion</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(30,000</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(135,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-align: justify">Long term portion</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the three months ended,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid">March 28, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Warranty Reserve Activity:</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right"> </td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt">Beginning balance</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">8,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Additions</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Deductions</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 10pt">Ending balance</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">8,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

8. Subsequent Events   On May 14, 2021, the Company entered into an agreement and plan of merger with Allied Integral United, Inc. (known as “Clearday”) and a wholly-owned subsidiary of the Company. The agreement terminates the earlier merger agreement between the same parties, dated February 26, 2020, without liability. Subject to satisfaction of the conditions to closing of the merger, which include customary conditions and a minimum net working capital condition, the Company will issue common stock to the shareholders of Clearday such that, at the closing of the merger, the Company’s stockholders, and the Clearday stockholders would own, respectively, approximately 96.35% and 3.65% of the combined company’s outstanding shares. The merger agreement was approved by boards of directors of both companies and is subject to stockholder approval. Assuming satisfaction of conditions, the merger is expected to close in the third quarter of 2021. Clearday was incorporated on December 20, 2017 and commenced its business on December 31, 2018 when it acquired private funds that engaged in several businesses that have been conducted for the prior 15 years. Since December 2018, Clearday has been engaged in developing and providing the next generation of technology-enabled longevity care and wellness solutions, in alignment with the changing characteristics, expectations, and behaviors of the longevity consumer market.

Principles of Consolidation   The interim condensed consolidated financial statements include the accounts of Superconductor Technologies Inc. and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated from the condensed consolidated financial statements.

Cash and Cash Equivalents   Cash and cash equivalents consist of highly liquid investments with original maturities of three months or less. Cash and cash equivalents are maintained with what we believe to be quality financial institutions and exceed FDIC limits. Historically, we have not experienced any losses due to such concentration of credit risk.

Accounts Receivable   We grant uncollateralized credit to our customers. We perform usual and customary credit evaluations of our customers before granting credit. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on historical write-off experience. Past due balances are reviewed for collectability. Accounts balances are charged off against the allowance when we deem it is probable the receivable will not be recovered. We do not have any off-balance sheet credit exposure related to our customers.

Revenue Recognition   On January 1, 2018, we adopted ASC Topic 606, Revenue from Contracts with Customers, and all of the related amendments (“ASC 606”) and applied it to all contracts. The adoption ASC topic 606 has had no effect to our consolidated financial statements.   Commercial and government contract revenues are recognized once all of the following conditions have been met: a) an authorized purchase order has been received in writing, b) the customer’s credit worthiness has been established, c) shipment of the product has occurred, d) title has transferred, and e) if stipulated by the contract, customer acceptance has occurred and all significant vendor obligations, if any, have been satisfied.   Government contract revenues are principally generated under research and development contracts. Revenues from research-related activities are derived from contracts with agencies of the U.S. Government. Credit risk related to accounts receivable arising from such contracts is considered minimal. All payments to us for work performed on contracts with agencies of the U.S. Government are subject to adjustment upon audit by the Defense Contract Audit Agency. Based on historical experience and review of our current project in process, we believe that adjustments from open audits will not have an effect on our financial position, results of operations or cash flows. We are using the expected cost-plus-margin approach as the suitable method for allocating transaction price to the performance obligations in the contract under ASC 606.

Shipping and Handling Fees and Costs   Shipping and handling fees billed to customers are included in net revenues. Shipping and handling fees associated with freight are generally included in cost of revenues.

Warranties   We offer warranties generally ranging from one to five years, depending on the product and negotiated terms of purchase agreements with our customers. Such warranties require us to repair or replace defective products returned to us during such warranty period at no cost to the customer. An estimate by us for warranty related costs is recorded by us at the time of sale based on our actual historical product return rates and expected repair costs. Such costs have been within our expectations.

Indemnities   In connection with the sales and manufacturing of our commercial products, we indemnify, without limit or term, our customers and contract manufacturers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to our products or other claims arising from our products. We cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under our indemnities because of the uncertainty as to whether a claim might arise and how much it might total. Historically, we have not incurred any expenses related to these indemnities.

Research and Development Costs   Research and development costs are charged to expense as incurred and include salary, facility, depreciation and material expenses. Research and development costs are charged to research and development expense.

Inventories   Inventories were stated at the lower of cost or net realizable value, with costs primarily determined using standard costs, which approximate actual costs utilizing the first-in, first-out method. We review inventory quantities on hand and on order and record, on a quarterly basis, a provision for excess and obsolete inventory and/or vendor cancellation charges related to purchase commitments. If the results of the review determine that a write-down is necessary, we recognize a loss in the period in which the loss is identified, whether or not the inventory is retained. Our April 3, 2021 and December 31, 2020 net inventory value was $68,000. During the three month period ending March 28, 2020 we ceased production of our Conductus wire and expensed the remaining $190,000 of wire inventory.

Preferred interest in real estate   We entered into a Securities Purchase Agreement with Clearday, which was consummated on July 6, 2020, pursuant to which we issued 400,000 shares of our common stock in exchange for a preferred interest in real estate we value at $1.6 million, implying a purchase price of $4.00 per share, based on the intraday stock trading price. The fair value of the real estate was based on the fact the building was acquired by Clearday in an arm’s-length all-cash purchase in November 2019 and a recent broker’s price report.

Property and Equipment   Property and equipment are recorded at cost. Equipment is depreciated using the straight-line method over their estimated useful lives ranging from three to five years. Leasehold improvements and assets financed under capital leases are amortized over the shorter of their useful lives or the lease term. Furniture and fixtures are depreciated over seven years. Expenditures for additions and major improvements are capitalized. Expenditures for minor tooling, repairs and maintenance and minor improvements are charged to expense as incurred. When property or equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts. Gains or losses from retirements and disposals are recorded in selling, general and administration expenses. During the three month period ending March 28, 2020 we ceased production of our Conductus wire and sold most of our production wire equipment for a gain of $510,000.

Patents, Licenses and Purchased Technology   Patents and licenses are recorded at cost and are amortized using the straight-line method over the shorter of their estimated useful lives or seventeen years. During the three month period ending March 28, 2020 we ceased production of our Conductus wire and sold many Conductus wire patents for no gain or loss and we also recognized a $134,000 impairment of other patents.

Other Assets and Investments   The realizability of long-lived assets is evaluated periodically as events or circumstances indicate a possible inability to recover the carrying amount. Long-lived assets that will no longer be used in the business are written off in the period identified since they will no longer be used in operations and generate any positive cash flows for us. Periodically, long-lived assets that will continue to be used by us will need to be evaluated for recoverability. Such evaluation is based on various analyses, including cash flow and profitability projections, as well as alternative uses, such as government contracts or awards. The analyses necessarily involve significant management judgment. In the event the projected undiscounted cash flows are less than net book value of the assets, the carrying value of the assets will be written down to their estimated fair value. We tested our long-lived assets at April 3, 2021 and none of our long-lived assets had book value.

Loss Contingencies   In the normal course of our business, we are subject to claims and litigation, including allegations of patent infringement. Liabilities relating to these claims are recorded when it is determined that a loss is probable and the amount of the loss can be reasonably estimated. Legal fees are recorded as services are provided. The costs of our defense in such matters are charged to operations as incurred. Insurance proceeds recoverable are recorded when deemed probable.

Marketing Costs   All costs related to marketing and advertising our products are charged to expense as incurred or at the time the advertising takes place. Advertising costs were not material in each of the quarters ended April 3, 2021 and March 28, 2020.

Net Loss Per Share   Basic and diluted net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding in each year. Net loss available to common stockholders is computed after deducting accumulated dividends on cumulative preferred stock, deemed dividends and accretion of redemption value on redeemable preferred stock for the period and beneficial conversion features on issuance of convertible preferred stock. Potential common shares are not included in the calculation of diluted loss per share because their effect is anti-dilutive.

Stock-based Compensation Expense   We grant both restricted stock awards and stock options to our key employees, directors and consultants. For the quarters ended April 3, 2021 and March 28, 2020, no options or awards were granted. The following table presents details of total stock-based compensation expense that is included in each functional line item on our condensed consolidated statements of operations:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Three months ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 28, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%">Cost of commercial product revenues</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 18%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 18%; text-align: right">1,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Research and development</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Selling, general and administrative</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">18,000</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total stock-based compensation expense</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">21,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

Use of Estimates   The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The significant estimates in the preparation of the financial statements relate to the assessment of the carrying amount of accounts receivable, fixed assets, intangibles, estimated provisions for warranty costs, fair value of warrant derivatives, income taxes and disclosures related to litigation. Actual results could differ from those estimates and such differences may be material to the condensed consolidated financial statements.

Fair Value of Financial Instruments   We have estimated the fair value amounts of our financial instruments using the available market information and valuation methodologies considered appropriate. We determined the book value of our cash and cash equivalents, and other current liabilities according to their approximate fair value as of April 3, 2021.

Comprehensive Income   We have no items of other comprehensive income in any period and consequently have not included a Statement of Comprehensive Income.

Segment Information   We have historically operated in a single business segment: the research, development, manufacture and marketing of high performance products used in cellular base stations. We derived net commercial product revenues primarily from the sales of our AmpLink and SuperPlex products which we sold directly to wireless network operators in the United States. Net revenues derived principally from government contracts are presented separately on the consolidated statements of operations for all periods presented.

Certain Risks and Uncertainties   On January 28, 2020, we announced a cost reduction plan for the purpose of aligning our personnel needs and capital requirements as we explored strategic alternatives previously announced. We will maintain operations of our Sapphire Cryocooler cryogenics initiatives while ceasing additional manufacturing of our HTS Conductus® wire. The plan also included a 70% employee workforce reduction.   On February 26, 2020, we entered into a definitive merger agreement Clearday a privately-held company dedicated to delivering next generation longevity care and wellness services, whereby a wholly-owned subsidiary of STI will merge with and into Clearday in a stock-for-stock transaction with Clearday, with Clearday surviving and becoming a wholly-owned subsidiary of STI, which will then change its name to Clearday, Inc. See “Our Future Business” above for more information.

The following is a summary of stock option transactions under our Stock Option Plans at April 3, 2021:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Number of Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price Per Share</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Number of Options Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 35%">Balance at December 31, 2020</td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: center">7,863</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">19.20 - $ 28,440</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 9%; text-align: right">255.90</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right">7,863</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 9%; text-align: right">255.90</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td style="text-align: center">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Exercised</td> <td> </td> <td style="text-align: center">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Canceled</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">12</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">28,440</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">28,440</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">12</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">28,440</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Balance at April 3, 2021</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; text-align: center">7,851</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">19.20 - $ 26,280</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">211.24</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">7,851</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">211.24</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

The following is a summary of outstanding warrants at April 3, 2021:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">Common Shares</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Currently Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price per Share</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Expiration Date</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%">Warrants related to August 2016 financing</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">5,350</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">5,350</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">300.00</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: right">February 2, 2022</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants related to August 2016 financing</td> <td> </td> <td> </td> <td style="text-align: right">500</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">500</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">385.50</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">August 2, 2021</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Warrants related to December 2016 financing</td> <td> </td> <td> </td> <td style="text-align: right">68,567</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">68,567</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">200.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">December 14, 2021</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants related to March 2018 financing</td> <td> </td> <td> </td> <td style="text-align: right">15,810</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">15,810</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">114.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">September 9, 2023</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Warrants related to March 2018 financing</td> <td> </td> <td> </td> <td style="text-align: right">1,107</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,107</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">158.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">March 6, 2023</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants related to July 2018 financing</td> <td> </td> <td> </td> <td style="text-align: right">257,143</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">257,143</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">35.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">July 25, 2023</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Warrants related to July 2018 financing</td> <td> </td> <td> </td> <td style="text-align: right">15,428</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">15,428</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">43.75</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">July 25, 2023</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants related to May 2019 financing</td> <td> </td> <td> </td> <td style="text-align: right">11,900</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">11,900</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">12.50</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">May 23, 2024</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Warrants related to October 2019 financing</td> <td> </td> <td> </td> <td style="text-align: right">217,200</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">217,200</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">2.50</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">October 10, 2024</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants related to October 2019 financing</td> <td> </td> <td> </td> <td style="text-align: right">30,916</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">30,916</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">3.13</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">October 8, 2024</td> <td> </td></tr> </table>

Since their impact would be anti-dilutive, our net loss per common share does not include the effect of the assumed exercise or vesting of the following shares:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 28, 2020</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%">Outstanding stock options</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: right">7,851</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: right">12,141</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Unvested restricted stock awards</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">33</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Outstanding warrants</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">623,921</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">1,062,819</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">631,772</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">1,074,993</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Property and Equipment:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Equipment</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%">$</td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right">316,000</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%">$</td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right">316,000</td> <td style="width: 1%; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Less: accumulated depreciation and amortization</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">316,000</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(316,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Patents and Licenses:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt; text-align: justify">Patents issued</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">278,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 16%; text-align: right">278,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Less accumulated amortization</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(278,000</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(278,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Net patents issued</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; text-align: justify"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify">Accrued Expenses and Other Long Term Liabilities:</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt; text-align: justify">Salaries Payable</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">30,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">10,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Compensated absences</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">125,000</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td> </td> <td style="text-align: right">30,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">135,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; padding-left: 10pt; text-align: justify">Less current portion</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(30,000</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(135,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt; text-align: justify">Long term portion</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">For the three months ended,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid">March 28, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Warranty Reserve Activity:</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: right"> </td> <td style="padding-bottom: 2.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-left: 10pt">Beginning balance</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 16%; text-align: right">8,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt">Additions</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; padding-left: 10pt">Deductions</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 10pt">Ending balance</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">8,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

0.70 1075000

120000

Expire in the years 2021 through 2038 19.20 26280

7851

211.24

555171 1388000 1383000

21000

0.9635

0.0365

Clearday was incorporated on December 20, 2017 and commenced its business on December 31, 2018 when it acquired private funds that engaged in several businesses that have been conducted for the prior 15 years. Since December 2018,

0.0100

27000

11000

1000

20000

0.00

0.01

1700000

28440

334632000

334752000

P7Y2M12D

28440 -316000 316000 120000 120000

Income Taxes   We recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized. The guidance further clarifies the accounting for uncertainty in income taxes and sets a consistent framework to determine the appropriate level of tax reserve to maintain for uncertain tax positions. This interpretation uses a two-step approach wherein a tax benefit is recognized if a position is more-likely-than-not to be sustained. The amount of the benefit is then measured to be the highest tax benefit that is greater than 50% likely to be realized and sets out disclosure requirements to enhance transparency of our tax reserves. Unrecognized tax positions, if ever recognized in the condensed consolidated financial statements, are recorded in the statement of operations as part of the income tax provision. Our policy is to recognize interest and penalties accrued on uncertain tax positions, if any, as part of the income tax provision.   No liabilities for uncertain tax positions were recorded in the current year. No interest or penalties on uncertain tax positions have been expensed to date. We are not under examination by any taxing authorities. Our federal statute of limitations for examination of us is open for 2016 and subsequent filings.   As of December 31, 2020, we had net operating loss carryforwards for federal and state income tax purposes. We concluded that under the Internal Revenue Code change of control limitations, a maximum of $14.2 million of our $297.9 net operating loss carryforwards, which expire in the years 2021 through 2038, would be available for reduction of taxable income and reduced both the deferred tax asset and valuation allowance accordingly. Due to the uncertainty surrounding their realization, we recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying condensed consolidated balance sheets.

Basis of Presentation   We have incurred significant net losses since our inception and have an accumulated deficit of $332.5 million. In the three months ended April 3, 2021, we incurred a net loss of $569,000 and negative cash flows from operations of $453,000. In 2020, we incurred a net loss of $3.0 million and had negative cash flows from operations of $3.1 million. In 2020, we had an accumulated deficit of $331.9 million, a net loss of $9.2 million and negative cash flows from operations of $8.8 million. At December 31, 2020, we had $1.3 million in cash. Our cash resources may therefore not be sufficient to fund our business through the end of the current fiscal year. Therefore, unless we can successfully implement our strategic alternatives plan including, among others, a strategic investment financing which would allow us to pursue our current business plan, a business combination such as our merger with Clearday, or a sale of STI, we will need to raise additional capital during this fiscal year ending December 31, 2021 to maintain our viability. Additional financing may not be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. These factors raise substantial doubt about our ability to continue as a going concern.   Our plans regarding improving our future liquidity will require us to successfully implement our strategic plan to explore strategic alternatives focused on maximizing shareholder value. Strategic alternatives considered included, among others, a strategic investment financing which would allow the company to pursue its current business plan, a business combination such as a merger with another party, or a sale of STI. On January 28, 2020, we announced a cost reduction plan for the purpose of aligning our personnel needs and capital requirements as we explored strategic alternatives previously announced. We will maintain operations of our Sapphire Cryocooler cryogenics initiatives while ceasing additional manufacturing of our HTS Conductus® wire. The plan also included a 70% employee workforce reduction.   In 2019, we undertook steps to reduce our ongoing operating costs and we raised net cash proceeds of $3.9 million from the sale of our common and preferred shares and warrants.   On September 9, 2020, we effected a 1-for-10 reverse stock split of our common stock, or the 2020 Reverse Stock Split. As a result of the 2020 Reverse Stock Split, every ten shares of our pre-2020 Reverse Stock Split common stock were combined and reclassified into one share of our common stock. The 2020 Reverse Stock Split changed the authorized number of shares from 250,000,000 to 25,000,000. The par value of our common stock remained $0.001.   Share and per share data included in the Notes to Consolidated Financial Statements have been retroactively adjusted, as applicable, for the effect of the reverse stock splits. Certain of the information contained in the documents incorporated by reference herein and therein present information on our common stock on a pre-reverse stock split basis.

2. Summary of Significant Accounting Policies   Basis of Presentation   We have incurred significant net losses since our inception and have an accumulated deficit of $332.5 million. In the three months ended April 3, 2021, we incurred a net loss of $569,000 and negative cash flows from operations of $453,000. In 2020, we incurred a net loss of $3.0 million and had negative cash flows from operations of $3.1 million. In 2020, we had an accumulated deficit of $331.9 million, a net loss of $9.2 million and negative cash flows from operations of $8.8 million. At December 31, 2020, we had $1.3 million in cash. Our cash resources may therefore not be sufficient to fund our business through the end of the current fiscal year. Therefore, unless we can successfully implement our strategic alternatives plan including, among others, a strategic investment financing which would allow us to pursue our current business plan, a business combination such as our merger with Clearday, or a sale of STI, we will need to raise additional capital during this fiscal year ending December 31, 2021 to maintain our viability. Additional financing may not be available on acceptable terms or at all. If we issue additional equity securities to raise funds, the ownership percentage of our existing stockholders would be reduced. New investors may demand rights, preferences or privileges senior to those of existing holders of common stock. These factors raise substantial doubt about our ability to continue as a going concern.   Our plans regarding improving our future liquidity will require us to successfully implement our strategic plan to explore strategic alternatives focused on maximizing shareholder value. Strategic alternatives considered included, among others, a strategic investment financing which would allow the company to pursue its current business plan, a business combination such as a merger with another party, or a sale of STI. On January 28, 2020, we announced a cost reduction plan for the purpose of aligning our personnel needs and capital requirements as we explored strategic alternatives previously announced. We will maintain operations of our Sapphire Cryocooler cryogenics initiatives while ceasing additional manufacturing of our HTS Conductus® wire. The plan also included a 70% employee workforce reduction.   In 2019, we undertook steps to reduce our ongoing operating costs and we raised net cash proceeds of $3.9 million from the sale of our common and preferred shares and warrants.   On September 9, 2020, we effected a 1-for-10 reverse stock split of our common stock, or the 2020 Reverse Stock Split. As a result of the 2020 Reverse Stock Split, every ten shares of our pre-2020 Reverse Stock Split common stock were combined and reclassified into one share of our common stock. The 2020 Reverse Stock Split changed the authorized number of shares from 250,000,000 to 25,000,000. The par value of our common stock remained $0.001.   Share and per share data included in the Notes to Consolidated Financial Statements have been retroactively adjusted, as applicable, for the effect of the reverse stock splits. Certain of the information contained in the documents incorporated by reference herein and therein present information on our common stock on a pre-reverse stock split basis.   Principles of Consolidation   The interim condensed consolidated financial statements include the accounts of Superconductor Technologies Inc. and its wholly owned subsidiaries. All significant intercompany transactions have been eliminated from the condensed consolidated financial statements.   Cash and Cash Equivalents   Cash and cash equivalents consist of highly liquid investments with original maturities of three months or less. Cash and cash equivalents are maintained with what we believe to be quality financial institutions and exceed FDIC limits. Historically, we have not experienced any losses due to such concentration of credit risk.   Accounts Receivable   We grant uncollateralized credit to our customers. We perform usual and customary credit evaluations of our customers before granting credit. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based on historical write-off experience. Past due balances are reviewed for collectability. Accounts balances are charged off against the allowance when we deem it is probable the receivable will not be recovered. We do not have any off-balance sheet credit exposure related to our customers.   Revenue Recognition   On January 1, 2018, we adopted ASC Topic 606, Revenue from Contracts with Customers, and all of the related amendments (“ASC 606”) and applied it to all contracts. The adoption ASC topic 606 has had no effect to our consolidated financial statements.   Commercial and government contract revenues are recognized once all of the following conditions have been met: a) an authorized purchase order has been received in writing, b) the customer’s credit worthiness has been established, c) shipment of the product has occurred, d) title has transferred, and e) if stipulated by the contract, customer acceptance has occurred and all significant vendor obligations, if any, have been satisfied.   Government contract revenues are principally generated under research and development contracts. Revenues from research-related activities are derived from contracts with agencies of the U.S. Government. Credit risk related to accounts receivable arising from such contracts is considered minimal. All payments to us for work performed on contracts with agencies of the U.S. Government are subject to adjustment upon audit by the Defense Contract Audit Agency. Based on historical experience and review of our current project in process, we believe that adjustments from open audits will not have an effect on our financial position, results of operations or cash flows. We are using the expected cost-plus-margin approach as the suitable method for allocating transaction price to the performance obligations in the contract under ASC 606.   Shipping and Handling Fees and Costs   Shipping and handling fees billed to customers are included in net revenues. Shipping and handling fees associated with freight are generally included in cost of revenues.   Warranties   We offer warranties generally ranging from one to five years, depending on the product and negotiated terms of purchase agreements with our customers. Such warranties require us to repair or replace defective products returned to us during such warranty period at no cost to the customer. An estimate by us for warranty related costs is recorded by us at the time of sale based on our actual historical product return rates and expected repair costs. Such costs have been within our expectations.   Indemnities   In connection with the sales and manufacturing of our commercial products, we indemnify, without limit or term, our customers and contract manufacturers against all claims, suits, demands, damages, liabilities, expenses, judgments, settlements and penalties arising from actual or alleged infringement or misappropriation of any intellectual property relating to our products or other claims arising from our products. We cannot reasonably develop an estimate of the maximum potential amount of payments that might be made under our indemnities because of the uncertainty as to whether a claim might arise and how much it might total. Historically, we have not incurred any expenses related to these indemnities.   Research and Development Costs   Research and development costs are charged to expense as incurred and include salary, facility, depreciation and material expenses. Research and development costs are charged to research and development expense.   Inventories   Inventories were stated at the lower of cost or net realizable value, with costs primarily determined using standard costs, which approximate actual costs utilizing the first-in, first-out method. We review inventory quantities on hand and on order and record, on a quarterly basis, a provision for excess and obsolete inventory and/or vendor cancellation charges related to purchase commitments. If the results of the review determine that a write-down is necessary, we recognize a loss in the period in which the loss is identified, whether or not the inventory is retained. Our April 3, 2021 and December 31, 2020 net inventory value was $68,000. During the three month period ending March 28, 2020 we ceased production of our Conductus wire and expensed the remaining $190,000 of wire inventory.   Preferred interest in real estate   We entered into a Securities Purchase Agreement with Clearday, which was consummated on July 6, 2020, pursuant to which we issued 400,000 shares of our common stock in exchange for a preferred interest in real estate we value at $1.6 million, implying a purchase price of $4.00 per share, based on the intraday stock trading price. The fair value of the real estate was based on the fact the building was acquired by Clearday in an arm’s-length all-cash purchase in November 2019 and a recent broker’s price report.   Property and Equipment   Property and equipment are recorded at cost. Equipment is depreciated using the straight-line method over their estimated useful lives ranging from three to five years. Leasehold improvements and assets financed under capital leases are amortized over the shorter of their useful lives or the lease term. Furniture and fixtures are depreciated over seven years. Expenditures for additions and major improvements are capitalized. Expenditures for minor tooling, repairs and maintenance and minor improvements are charged to expense as incurred. When property or equipment is retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the accounts. Gains or losses from retirements and disposals are recorded in selling, general and administration expenses. During the three month period ending March 28, 2020 we ceased production of our Conductus wire and sold most of our production wire equipment for a gain of $510,000.   Patents, Licenses and Purchased Technology   Patents and licenses are recorded at cost and are amortized using the straight-line method over the shorter of their estimated useful lives or seventeen years. During the three month period ending March 28, 2020 we ceased production of our Conductus wire and sold many Conductus wire patents for no gain or loss and we also recognized a $134,000 impairment of other patents.   Other Assets and Investments   The realizability of long-lived assets is evaluated periodically as events or circumstances indicate a possible inability to recover the carrying amount. Long-lived assets that will no longer be used in the business are written off in the period identified since they will no longer be used in operations and generate any positive cash flows for us. Periodically, long-lived assets that will continue to be used by us will need to be evaluated for recoverability. Such evaluation is based on various analyses, including cash flow and profitability projections, as well as alternative uses, such as government contracts or awards. The analyses necessarily involve significant management judgment. In the event the projected undiscounted cash flows are less than net book value of the assets, the carrying value of the assets will be written down to their estimated fair value. We tested our long-lived assets at April 3, 2021 and none of our long-lived assets had book value.   Loss Contingencies   In the normal course of our business, we are subject to claims and litigation, including allegations of patent infringement. Liabilities relating to these claims are recorded when it is determined that a loss is probable and the amount of the loss can be reasonably estimated. Legal fees are recorded as services are provided. The costs of our defense in such matters are charged to operations as incurred. Insurance proceeds recoverable are recorded when deemed probable.   Income Taxes   We recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized. The guidance further clarifies the accounting for uncertainty in income taxes and sets a consistent framework to determine the appropriate level of tax reserve to maintain for uncertain tax positions. This interpretation uses a two-step approach wherein a tax benefit is recognized if a position is more-likely-than-not to be sustained. The amount of the benefit is then measured to be the highest tax benefit that is greater than 50% likely to be realized and sets out disclosure requirements to enhance transparency of our tax reserves. Unrecognized tax positions, if ever recognized in the condensed consolidated financial statements, are recorded in the statement of operations as part of the income tax provision. Our policy is to recognize interest and penalties accrued on uncertain tax positions, if any, as part of the income tax provision.   No liabilities for uncertain tax positions were recorded in the current year. No interest or penalties on uncertain tax positions have been expensed to date. We are not under examination by any taxing authorities. Our federal statute of limitations for examination of us is open for 2016 and subsequent filings.   As of December 31, 2020, we had net operating loss carryforwards for federal and state income tax purposes. We concluded that under the Internal Revenue Code change of control limitations, a maximum of $14.2 million of our $297.9 net operating loss carryforwards, which expire in the years 2021 through 2038, would be available for reduction of taxable income and reduced both the deferred tax asset and valuation allowance accordingly. Due to the uncertainty surrounding their realization, we recorded a full valuation allowance against our net deferred tax assets. Accordingly, no deferred tax asset has been recorded in the accompanying condensed consolidated balance sheets.   Marketing Costs   All costs related to marketing and advertising our products are charged to expense as incurred or at the time the advertising takes place. Advertising costs were not material in each of the quarters ended April 3, 2021 and March 28, 2020.   Net Loss Per Share   Basic and diluted net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding in each year. Net loss available to common stockholders is computed after deducting accumulated dividends on cumulative preferred stock, deemed dividends and accretion of redemption value on redeemable preferred stock for the period and beneficial conversion features on issuance of convertible preferred stock. Potential common shares are not included in the calculation of diluted loss per share because their effect is anti-dilutive.   Stock-based Compensation Expense   We grant both restricted stock awards and stock options to our key employees, directors and consultants. For the quarters ended April 3, 2021 and March 28, 2020, no options or awards were granted. The following table presents details of total stock-based compensation expense that is included in each functional line item on our condensed consolidated statements of operations:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Three months ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 28, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%">Cost of commercial product revenues</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 18%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 18%; text-align: right">1,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Research and development</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Selling, general and administrative</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">18,000</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total stock-based compensation expense</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">21,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   Use of Estimates   The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The significant estimates in the preparation of the financial statements relate to the assessment of the carrying amount of accounts receivable, fixed assets, intangibles, estimated provisions for warranty costs, fair value of warrant derivatives, income taxes and disclosures related to litigation. Actual results could differ from those estimates and such differences may be material to the condensed consolidated financial statements.   Fair Value of Financial Instruments   We have estimated the fair value amounts of our financial instruments using the available market information and valuation methodologies considered appropriate. We determined the book value of our cash and cash equivalents, and other current liabilities according to their approximate fair value as of April 3, 2021.   Comprehensive Income   We have no items of other comprehensive income in any period and consequently have not included a Statement of Comprehensive Income.   Segment Information   We have historically operated in a single business segment: the research, development, manufacture and marketing of high performance products used in cellular base stations. We derived net commercial product revenues primarily from the sales of our AmpLink and SuperPlex products which we sold directly to wireless network operators in the United States. Net revenues derived principally from government contracts are presented separately on the consolidated statements of operations for all periods presented.   Certain Risks and Uncertainties   On January 28, 2020, we announced a cost reduction plan for the purpose of aligning our personnel needs and capital requirements as we explored strategic alternatives previously announced. We will maintain operations of our Sapphire Cryocooler cryogenics initiatives while ceasing additional manufacturing of our HTS Conductus® wire. The plan also included a 70% employee workforce reduction.   On February 26, 2020, we entered into a definitive merger agreement Clearday a privately-held company dedicated to delivering next generation longevity care and wellness services, whereby a wholly-owned subsidiary of STI will merge with and into Clearday in a stock-for-stock transaction with Clearday, with Clearday surviving and becoming a wholly-owned subsidiary of STI, which will then change its name to Clearday, Inc. See “Our Future Business” above for more information.

3. Stockholders’ Equity   The following is a summary of stockholders’ equity transactions for the three months ended April 3, 2021:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="padding-bottom: 1.5pt; text-align: center">Convertible</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Capital in</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Preferred Stock</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Common Stock</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Excess of</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Accumulated</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Amount</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Amount</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Par Value</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Deficit</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%">Balance at December 31, 2020</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 5%; text-align: right">328,925</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 5%; text-align: right">3,151,780</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">3,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">334,632,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">(331,930,000</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">2,705,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Merger partner contribution</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">120,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">120,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Net loss</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(569,000</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(569,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balance at April 3, 2021</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">328,925</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">3,151,780</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">3,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">334,752,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(332,499,000</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,256,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   The following is a summary of stockholders’ equity transactions for the three months ended March 28, 2020:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="padding-bottom: 1.5pt; text-align: center">Convertible</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Capital in</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Preferred Stock</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Common Stock</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Excess of</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Accumulated</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Amount</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Amount</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Par Value</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Deficit</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%">Balance at December 31, 2019</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 5%; text-align: right">328,925</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 5%; text-align: right">1,773,189</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">2,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">330,474,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">(328,973,000</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">1,503,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrant exercises</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">555,171</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,383,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,388,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Stock-based compensation</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">21,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">21,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Net loss</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(1,079,000</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(1,079,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Balance at March 28, 2020</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">328,925</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2,328,360</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">331,878,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(330,052,000</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,833,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   Stock Options   At April 3, 2021, we had two active equity award option plans, the 2003 Equity Incentive Plan and the 2013 Equity Incentive Plan (collectively, the “Stock Option Plan”), although we can only grant new options under the 2013 Equity Incentive Plan. Under our Stock Option Plan, stock awards were made to our directors, key employees, consultants, and non-employee directors and consisted of stock options, restricted stock awards, performance awards, and performance share awards. Stock options were granted at prices no less than the market value on the date of grant. There were no stock option exercises during the three months ended April 3, 2021 or during the three months ended March 28, 2020.   The impact to the condensed consolidated statements of operations for the quarter ended April 3, 2021 on net loss was $0 and $0.00 on basic and diluted net loss per common share and for the quarter ended March 28, 2020 the impact was $20,000 and $0.01 on basic and diluted net loss per common share. No stock compensation cost was capitalized during either period. The total compensation cost related to nonvested awards not yet recognized was $0.   The following is a summary of stock option transactions under our Stock Option Plans at April 3, 2021:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">Number of Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price Per Share</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Number of Options Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Weighted Average Exercise Price</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 35%">Balance at December 31, 2020</td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: center">7,863</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 15%; text-align: right">19.20 - $ 28,440</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 9%; text-align: right">255.90</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right">7,863</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 9%; text-align: right">255.90</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Granted</td> <td> </td> <td style="text-align: center">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Exercised</td> <td> </td> <td style="text-align: center">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Canceled</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">12</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">28,440</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">28,440</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">12</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">28,440</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Balance at April 3, 2021</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; text-align: center">7,851</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">19.20 - $ 26,280</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">211.24</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">7,851</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">211.24</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   The outstanding options expire on various dates through the end of October 2028. The weighted-average contractual term of options outstanding is 7.2 years and the weighted-average contractual term of stock options currently exercisable is 7.2 years. The exercise prices for these options range from $19.20 to $26,280 per share, for a total weight-average exercise price of $1.7 million. At April 3, 2021, no options had an exercise price less than the current market value.   Restricted Stock Awards   The grant date fair value of each share of our restricted stock awards is equal to the fair value of our common stock at the grant date. Shares of restricted stock under awards all have service conditions and vest over one to three years. There were no restricted stock award transactions during the three months ended April 3, 2021.   The impact to the condensed consolidated statements of operations for the three months ended April 3, 2020 was $0 and $0.00 on basic and diluted net loss per common share and for the quarter ended March 28, 2020 the impact was $1,000 and $0.00 on basic and diluted net loss per common share. No stock compensation cost was capitalized during the period. There was no total compensation cost related to nonvested awards not yet recognized at April 3, 2021.   Warrants   The following is a summary of outstanding warrants at April 3, 2021:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center">Common Shares</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Currently Exercisable</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Price per Share</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Expiration Date</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%">Warrants related to August 2016 financing</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">5,350</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: right">5,350</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 10%; text-align: right">300.00</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: right">February 2, 2022</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants related to August 2016 financing</td> <td> </td> <td> </td> <td style="text-align: right">500</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">500</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">385.50</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">August 2, 2021</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Warrants related to December 2016 financing</td> <td> </td> <td> </td> <td style="text-align: right">68,567</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">68,567</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">200.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">December 14, 2021</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants related to March 2018 financing</td> <td> </td> <td> </td> <td style="text-align: right">15,810</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">15,810</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">114.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">September 9, 2023</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Warrants related to March 2018 financing</td> <td> </td> <td> </td> <td style="text-align: right">1,107</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,107</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">158.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">March 6, 2023</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants related to July 2018 financing</td> <td> </td> <td> </td> <td style="text-align: right">257,143</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">257,143</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">35.00</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">July 25, 2023</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Warrants related to July 2018 financing</td> <td> </td> <td> </td> <td style="text-align: right">15,428</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">15,428</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">43.75</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">July 25, 2023</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants related to May 2019 financing</td> <td> </td> <td> </td> <td style="text-align: right">11,900</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">11,900</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">12.50</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">May 23, 2024</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Warrants related to October 2019 financing</td> <td> </td> <td> </td> <td style="text-align: right">217,200</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">217,200</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">2.50</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">October 10, 2024</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrants related to October 2019 financing</td> <td> </td> <td> </td> <td style="text-align: right">30,916</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">30,916</td> <td> </td> <td> </td> <td>$</td> <td style="text-align: right">3.13</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">October 8, 2024</td> <td> </td></tr> </table>   On October 10, 2019 we completed a public offering of an aggregate of 1,183,400 shares of our common stock (or common stock equivalents) and warrants to purchase an aggregate of 1,183,400 shares of common stock with gross proceeds to us of approximately $3.0 million. The warrants are exercisable for five years at an exercise price equal to the public offering price. The offering was priced at $0.25 per share of common stock. The net proceeds to us from the offering, after deducting the placement agent fees and our estimated offering expenses, was approximately $2.4 million. The placement agent received warrants to purchase 82,838 shares of common stock, at an exercise price of $3.125, that will expire October 8, 2024 and are subject to a six month lock-up. In the quarter ended December 31, 2019, 39,528 of these warrants were exercised, providing us with proceeds of $99,000. In the quarter ended March 28, 2020, an additional 555,171 of these warrants were exercised, providing us with proceeds of $1.4 million.   On May 23, 2019 we completed a public offering of an aggregate of 170,000 shares of our common stock with gross proceeds to us of $1.7 million. The offering was priced at $10 per share of common stock. The net proceeds to us from the offering, after deducting the placement agent fees and our estimated offering expenses, was approximately $1.4 million. The placement agent received warrants to purchase 11,900 shares of common stock, at an exercise price of $1.25, that are subject to a nine month lock-up and will expire May 23, 2024.   Our warrants are exercisable by paying cash or, solely in the absence of an effective registration statement or prospectus, by cashless exercise for unregistered shares of common stock. The exercise price of the warrants is subject to standard antidilutive provision adjustment in the case of stock dividends or other distributions on shares of common stock or any other equity or equity equivalent securities payable in shares of common stock, stock splits, stock combinations, reclassifications or similar events affecting our common stock, and also, subject to limitations, upon any distribution of assets, including cash, stock or other property to our stockholders. The exercise price of the warrants is not subject to “price-based” anti-dilution adjustment. We have determined that these warrants related to issuance of common stock are subject to equity treatment because the warrant holder has no right to demand cash settlement and there are no unusual anti-dilution rights.

The following table presents details of total stock-based compensation expense that is included in each functional line item on our condensed consolidated statements of operations:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Three months ended</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">April 3, 2021</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 28, 2020</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%">Cost of commercial product revenues</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 18%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 18%; text-align: right">1,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Research and development</td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">2,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Selling, general and administrative</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">18,000</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Total stock-based compensation expense</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">21,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

The following is a summary of stockholders’ equity transactions for the three months ended April 3, 2021:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="padding-bottom: 1.5pt; text-align: center">Convertible</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Capital in</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Preferred Stock</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Common Stock</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Excess of</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Accumulated</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Amount</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Amount</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Par Value</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Deficit</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%">Balance at December 31, 2020</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 5%; text-align: right">328,925</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 5%; text-align: right">3,151,780</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">3,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">334,632,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">(331,930,000</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">2,705,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Merger partner contribution</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">120,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">120,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt">Net loss</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(569,000</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(569,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">Balance at April 3, 2021</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">328,925</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">3,151,780</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">3,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">334,752,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(332,499,000</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,256,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   The following is a summary of stockholders’ equity transactions for the three months ended March 28, 2020:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="padding-bottom: 1.5pt; text-align: center">Convertible</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Capital in</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Preferred Stock</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center">Common Stock</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Excess of</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Accumulated</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Amount</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Shares</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Amount</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Par Value</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Deficit</td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">Total</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%">Balance at December 31, 2019</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 5%; text-align: right">328,925</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">-</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 5%; text-align: right">1,773,189</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">2,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">330,474,000</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">(328,973,000</td> <td style="width: 1%">)</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 5%; text-align: right">1,503,000</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>Warrant exercises</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">555,171</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">-</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,383,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1,388,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>Stock-based compensation</td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">21,000</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">21,000</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Net loss</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(1,079,000</td> <td style="padding-bottom: 1.5pt">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">(1,079,000</td> <td style="padding-bottom: 1.5pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt">Balance at March 28, 2020</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">328,925</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">2,328,360</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">2,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">331,878,000</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">(330,052,000</td> <td style="padding-bottom: 2.5pt">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">1,833,000</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

EX-101.SCH 7 scon-20210403.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Loss Per Share link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Contractual Guarantees and Indemnities link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - General (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies - Schedule of Stock-Based Compensation Expense (Detail) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Stockholders' Equity - Summary of Stockholders' Equity Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Stockholders' Equity - Summary of Stock Option Transactions under Stock Option Plan (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Stockholders' Equity - Summary of Outstanding Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Loss Per Share (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Loss Per Share - Schedule of Antidilutive Shares Computation of Earnings (Loss) Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Patents and Licenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Accrued Expenses and Other Long Term Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Warranty Reserve Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 scon-20210403_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 scon-20210403_def.xml XBRL DEFINITION FILE EX-101.LAB 10 scon-20210403_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Capital in Excess of Par Value [Member] Accumulated Deficit [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patents and Licenses [Member] Class of Stock [Axis] Public Offering [Member] Warrant [Member] Placement Agent Warrant [Member] Class of Warrant or Right [Axis] Warrants Related to July 2018 Financing [Member] Warrants Related to August 2016 Financing [Member] Warrants Related to August 2016 Financing [Member] Warrants Related to December 2016 Financing [Member] Warrants Related to March 2018 Financing [Member] Warrants Related to March 2018 Financing [Member] Warrants Related to July 2018 Financing [Member] Warrants Related to May 2019 Financing [Member] Warrants Related to October 2019 Financing [Member] Warrants Related to October 2019 Financing [Member] Geographical [Axis] Austin, Texas [Member] Antidilutive Securities [Axis] Outstanding Stock Options [Member] Unvested Restricted Stock Awards [Member] Outstanding Warrants [Member] Long-Lived Tangible Asset [Axis] Equipment [Member] Patents Issued [Member] Convertible Preferred Stock [Member] Product and Service [Axis] Commercial Product [Member] Government Contract [Member] Title of Individual [Axis] Employee [Member] Business Acquisition [Axis] Clearday Inc [Member] Type Of Arrangement [Axis] New Merger Agreement [Member] Debt Instrument [Axis] Paycheck Protection Program Loan [Member] Income Statement Location [Axis] Cost of commercial product revenues [Member] Research and Development Expense [Member] Selling, General and Administrative Expenses [Member] Statistical Measurement [Axis] Maximum [Member] Award Type [Axis] Stock Option [Member] Plan Name [Axis] Stock Option Plans [Member] Minimum [Member] Licensing Agreements [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Merger Agreement [Member] Related Party [Axis] Company's Stockholders [Member] Clearday Stockholders [Member] Loans Insured or Guaranteed by Government Authorities [Axis] CARES Act [Member] Restricted Stock Awards [Member] Stock Options [Member] Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement [Table] Statement [Line Items] Total revenues Costs and expenses: Cost of revenues Research and development Selling, general and administrative Total costs and expenses Loss from operations Other Income and Expense: Other income Net loss Basic and diluted net loss per common share Basic and diluted weighted average number of common shares outstanding Statement of Financial Position [Abstract] ASSETS Current Assets: Cash and cash equivalents Inventories, net Prepaid expenses and other current assets Total Current Assets Preferred interest in real estate Total Assets LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable Accrued expenses Total Current Liabilities Long term debt Total Liabilities Commitments and Contingencies (Notes 5 and 6) Stockholders' Equity: Preferred stock, $.001 par value, 2,000,000 shares authorized, 328,925 and 328,925 shares issued and outstanding, respectively Common stock, $.001 par value, 25,000,000 shares authorized, 3,151,780 and 3,151,780 shares issued and outstanding, respectively Capital in excess of par value Accumulated deficit Total Stockholders' Equity Total Liabilities and Stockholders' Equity Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Stock-based compensation expense Gain from sale of property and equipment Write-down of intangibles Obsolete inventory Changes in assets and liabilities: Accounts receivable Inventories Prepaid expenses and other current assets Accounts payable, accrued expenses and other current liabilities Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Net proceeds from the sale of patents, property and equipment Net cash provided by investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Bank loan Net proceeds from the exercise of warrants Net cash provided by financing activities Net increase in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Organization, Consolidation and Presentation of Financial Statements [Abstract] General Accounting Policies [Abstract] Summary of Significant Accounting Policies Equity [Abstract] Stockholders' Equity Earnings Per Share [Abstract] Loss Per Share Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Text Block [Abstract] Contractual Guarantees and Indemnities Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities Subsequent Events [Abstract] Subsequent Events Basis of Presentation Principles of Consolidation Cash and Cash Equivalents Accounts Receivable Revenue Recognition Shipping and Handling Fees and Costs Warranties Indemnities Research and Development Costs Inventories Preferred Interest in Real Estate Property and Equipment Patents, Licenses and Purchased Technology Other Assets and Investments Loss Contingencies Income Taxes Marketing Costs Net Loss Per Share Stock-based Compensation Expense Use of Estimates Fair Value of Financial Instruments Comprehensive Income Segment Information Certain Risks and Uncertainties Schedule of Stock-Based Compensation Expense Summary of Stockholders' Equity Transactions EX-101.PRE 11 scon-20210403_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Apr. 03, 2021	May 11, 2021
Cover [Abstract]
Entity Registrant Name	SUPERCONDUCTOR TECHNOLOGIES INC
Entity Central Index Key	0000895665
Document Type	10-Q
Document Period End Date	Apr. 03, 2021
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		3,151,780
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Total revenues		$ 184,000
Costs and expenses:
Research and development		178,000
Selling, general and administrative	569,000	825,000
Total costs and expenses	569,000	1,264,000
Loss from operations	(569,000)	(1,080,000)
Other Income and Expense:
Other income		1,000
Net loss	$ (569,000)	$ (1,079,000)
Basic and diluted net loss per common share	$ (0.18)	$ (0.56)
Basic and diluted weighted average number of common shares outstanding	3,151,780	1,927,279
Commercial Product [Member]
Total revenues		$ 10,000
Costs and expenses:
Cost of revenues		190,000
Government Contract [Member]
Total revenues		174,000
Costs and expenses:
Cost of revenues		$ 71,000

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Apr. 03, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 1,291,000	$ 1,276,000
Inventories, net	68,000	68,000
Prepaid expenses and other current assets	19,000	76,000
Total Current Assets	1,378,000	1,420,000
Preferred interest in real estate	1,600,000	1,600,000
Total Assets	2,978,000	3,020,000
Current Liabilities:
Accounts payable	224,000	180,000
Accrued expenses	30,000	135,000
Total Current Liabilities	254,000	315,000
Long term debt	468,000
Total Liabilities	722,000	315,000
Commitments and Contingencies (Notes 5 and 6)
Stockholders' Equity:
Preferred stock, $.001 par value, 2,000,000 shares authorized, 328,925 and 328,925 shares issued and outstanding, respectively
Common stock, $.001 par value, 25,000,000 shares authorized, 3,151,780 and 3,151,780 shares issued and outstanding, respectively	3,000	3,000
Capital in excess of par value	334,752,000	334,632,000
Accumulated deficit	(332,499,000)	(331,930,000)
Total Stockholders' Equity	2,256,000	2,705,000
Total Liabilities and Stockholders' Equity	$ 2,978,000	$ 3,020,000

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Apr. 03, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	328,925	328,925
Preferred stock, shares outstanding	328,925	328,925
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	25,000,000	25,000,000
Common stock, shares issued	3,151,780	3,151,780
Common stock, shares outstanding	3,151,780	3,151,780

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Dec. 31, 2020	Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (569,000)	$ (1,079,000)	$ (2,957,000)	$ (9,229,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		38,000
Stock-based compensation expense		21,000
Gain from sale of property and equipment		(510,000)
Write-down of intangibles		134,000
Obsolete inventory		190,000
Changes in assets and liabilities:
Accounts receivable		(124,000)
Inventories		5,000
Prepaid expenses and other current assets	(57,000)	(58,000)
Accounts payable, accrued expenses and other current liabilities	173,000	(87,000)
Net cash used in operating activities	(453,000)	(1,470,000)	(3,138,000)	(8,803,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net proceeds from the sale of patents, property and equipment		1,212,000
Net cash provided by investing activities		1,212,000
CASH FLOWS FROM FINANCING ACTIVITIES:
Bank loan	468,000
Net proceeds from the exercise of warrants		1,388,000
Net cash provided by financing activities	468,000	1,388,000
Net increase in cash and cash equivalents	15,000	1,130,000
Cash and cash equivalents at beginning of period		713,000	$ 713,000
Cash and cash equivalents at end of period	$ 1,291,000	$ 1,843,000		$ 713,000

XML 17 R6.htm IDEA: XBRL DOCUMENT

General

3 Months Ended

Apr. 03, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

General

1.General

Please see “Our Future Business” below regarding material information and updates that in many material respects superseded and modify the following general business description.

We were established in 1987 shortly after the discovery of HTS materials. Our stated objective was to develop products based on these materials for the commercial marketplace.

After analyzing the market opportunities available, we decided to develop products for the utility and telecommunications industries.

Our Future Business

Clearday has paid us $120,000 as a good faith, non-refundable, payment to provide us cash flow support as we negotiate a new merger agreement.

XML 18 R7.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

3 Months Ended

Apr. 03, 2021

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation

In 2019, we undertook steps to reduce our ongoing operating costs and we raised net cash proceeds of $3.9 million from the sale of our common and preferred shares and warrants.

Principles of Consolidation

Cash and Cash Equivalents

Accounts Receivable

Revenue Recognition

Shipping and Handling Fees and Costs

Shipping and handling fees billed to customers are included in net revenues. Shipping and handling fees associated with freight are generally included in cost of revenues.

Warranties

Indemnities

Research and Development Costs

Inventories

Preferred interest in real estate

Property and Equipment

Patents, Licenses and Purchased Technology

Other Assets and Investments

Loss Contingencies

Income Taxes

Marketing Costs

Net Loss Per Share

Stock-based Compensation Expense

	Three months ended
	April 3, 2021		March 28, 2020
Cost of commercial product revenues	$	-	$	1,000
Research and development		-		2,000
Selling, general and administrative		-		18,000
Total stock-based compensation expense	$	-	$	21,000

Use of Estimates

Fair Value of Financial Instruments

Comprehensive Income

We have no items of other comprehensive income in any period and consequently have not included a Statement of Comprehensive Income.

Segment Information

Certain Risks and Uncertainties

On January 28, 2020, we announced a cost reduction plan for the purpose of aligning our personnel needs and capital requirements as we explored strategic alternatives previously announced. We will maintain operations of our Sapphire Cryocooler cryogenics initiatives while ceasing additional manufacturing of our HTS Conductus® wire. The plan also included a 70% employee workforce reduction.

XML 19 R8.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

3 Months Ended

Apr. 03, 2021

Equity [Abstract]

Stockholders' Equity

3. Stockholders’ Equity

The following is a summary of stockholders’ equity transactions for the three months ended April 3, 2021:

	Convertible								Capital in
	Preferred Stock				Common Stock				Excess of		Accumulated
	Shares		Amount		Shares		Amount		Par Value		Deficit			Total
Balance at December 31, 2020		328,925	$	-		3,151,780	$	3,000	$	334,632,000	$	(331,930,000	)	$	2,705,000
Merger partner contribution				-		-		-		120,000					120,000
Net loss												(569,000	)		(569,000	)
Balance at April 3, 2021		328,925	$	-		3,151,780	$	3,000	$	334,752,000	$	(332,499,000	)	$	2,256,000

The following is a summary of stockholders’ equity transactions for the three months ended March 28, 2020:

	Convertible								Capital in
	Preferred Stock				Common Stock				Excess of		Accumulated
	Shares		Amount		Shares		Amount		Par Value		Deficit			Total
Balance at December 31, 2019		328,925	$	-		1,773,189	$	2,000	$	330,474,000	$	(328,973,000	)	$	1,503,000
Warrant exercises				-		555,171		-		1,383,000					1,388,000
Stock-based compensation										21,000					21,000
Net loss												(1,079,000	)		(1,079,000	)
Balance at March 28, 2020		328,925	$	-		2,328,360	$	2,000	$	331,878,000	$	(330,052,000	)	$	1,833,000

Stock Options

The following is a summary of stock option transactions under our Stock Option Plans at April 3, 2021:

	Number of Shares	Price Per Share		Weighted Average Exercise Price		Number of Options Exercisable		Weighted Average Exercise Price
Balance at December 31, 2020	7,863	$	19.20 - $ 28,440	$	255.90		7,863	$	255.90
Granted	-				-
Exercised	-				-
Canceled	12		28,440		28,440		12		28,440
Balance at April 3, 2021	7,851	$	19.20 - $ 26,280	$	211.24		7,851	$	211.24

Restricted Stock Awards

Warrants

The following is a summary of outstanding warrants at April 3, 2021:

	Common Shares
	Total		Currently Exercisable		Price per Share		Expiration Date

Warrants related to August 2016 financing		5,350		5,350	$	300.00		February 2, 2022
Warrants related to August 2016 financing		500		500	$	385.50		August 2, 2021
Warrants related to December 2016 financing		68,567		68,567	$	200.00		December 14, 2021
Warrants related to March 2018 financing		15,810		15,810	$	114.00		September 9, 2023
Warrants related to March 2018 financing		1,107		1,107	$	158.00		March 6, 2023
Warrants related to July 2018 financing		257,143		257,143	$	35.00		July 25, 2023
Warrants related to July 2018 financing		15,428		15,428	$	43.75		July 25, 2023
Warrants related to May 2019 financing		11,900		11,900	$	12.50		May 23, 2024
Warrants related to October 2019 financing		217,200		217,200	$	2.50		October 10, 2024
Warrants related to October 2019 financing		30,916		30,916	$	3.13		October 8, 2024

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 20 R9.htm IDEA: XBRL DOCUMENT

Loss Per Share

3 Months Ended

Apr. 03, 2021

Earnings Per Share [Abstract]

Loss Per Share

4. Loss Per Share

Basic and diluted net loss per share is based on the weighted-average number of common shares outstanding.

Since their impact would be anti-dilutive, our net loss per common share does not include the effect of the assumed exercise or vesting of the following shares:

	April 3, 2021		March 28, 2020

Outstanding stock options		7,851		12,141
Unvested restricted stock awards		-		33
Outstanding warrants		623,921		1,062,819
Total		631,772		1,074,993

Also, the preferred stock convertible into 182 shares of common stock was not included since its impact would be anti-dilutive.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Apr. 03, 2021

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

5. Commitments and Contingencies

Operating Leases

For the three months ended April 3, 2021, operating lease expense was $0.

Patents and Licenses

We have no minimum payments under operating leases and license obligations going forward.

XML 22 R11.htm IDEA: XBRL DOCUMENT

Contractual Guarantees and Indemnities

3 Months Ended

Apr. 03, 2021

Text Block [Abstract]

Contractual Guarantees and Indemnities

6. Contractual Guarantees and Indemnities

Warranties

Intellectual Property Indemnities

Director and Officer Indemnities and Contractual Guarantees

General Contractual Indemnities/Products Liability

XML 23 R12.htm IDEA: XBRL DOCUMENT

Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities

3 Months Ended

Apr. 03, 2021

Text Block [Abstract]

Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities

7. Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities

Paycheck Protection Program Loan

Balance Sheet Data:

	April 3, 2021		December 31, 2020
Inventories:
Work In Process		68,000		68,000
	$	68,000	$	68,000

	April 3, 2021		December 31, 2020
Property and Equipment:
Equipment	$	316,000	$	316,000
		-
Less: accumulated depreciation and amortization		316,000		(316,000	)
	$	-	$	-

Depreciation expense amounted to $0 and $27,000 for the three month periods ended April 3, 2021 and March 28, 2020, respectively.

	April 3, 2021			December 31, 2020
Patents and Licenses:
Patents issued		278,000			278,000
Less accumulated amortization		(278,000	)		(278,000	)
Net patents issued		-			-
	$	-		$	-

	April 3, 2021			December 31, 2020
Accrued Expenses and Other Long Term Liabilities:
Salaries Payable	$	30,000		$	10,000
Compensated absences		-			125,000
		30,000			135,000
Less current portion		(30,000	)		(135,000	)
Long term portion	$	-		$	-

	For the three months ended,
	April 3, 2021		March 28, 2020
Warranty Reserve Activity:
Beginning balance	$	-	$	8,000
Additions		-		-
Deductions		-		-
Ending balance	$	-	$	8,000

XML 24 R13.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Apr. 03, 2021

Subsequent Events [Abstract]

Subsequent Events

8. Subsequent Events

XML 25 R14.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Apr. 03, 2021

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

In 2019, we undertook steps to reduce our ongoing operating costs and we raised net cash proceeds of $3.9 million from the sale of our common and preferred shares and warrants.

Principles of Consolidation

Principles of Consolidation

Cash and Cash Equivalents

Cash and Cash Equivalents

Accounts Receivable

Accounts Receivable

Revenue Recognition

Revenue Recognition

Shipping and Handling Fees and Costs

Shipping and Handling Fees and Costs

Shipping and handling fees billed to customers are included in net revenues. Shipping and handling fees associated with freight are generally included in cost of revenues.

Warranties

Warranties

Indemnities

Indemnities

Research and Development Costs

Research and Development Costs

Inventories

Inventories

Preferred Interest in Real Estate

Preferred interest in real estate

Property and Equipment

Property and Equipment

Patents, Licenses and Purchased Technology

Patents, Licenses and Purchased Technology

Other Assets and Investments

Other Assets and Investments

Income Taxes

Marketing Costs

Net Loss Per Share

Stock-based Compensation Expense

Stock-based Compensation Expense

	Three months ended
	April 3, 2021		March 28, 2020
Cost of commercial product revenues	$	-	$	1,000
Research and development		-		2,000
Selling, general and administrative		-		18,000
Total stock-based compensation expense	$	-	$	21,000

Use of Estimates

Use of Estimates

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Comprehensive Income

Comprehensive Income

We have no items of other comprehensive income in any period and consequently have not included a Statement of Comprehensive Income.

Segment Information

Segment Information

Certain Risks and Uncertainties

Certain Risks and Uncertainties

On January 28, 2020, we announced a cost reduction plan for the purpose of aligning our personnel needs and capital requirements as we explored strategic alternatives previously announced. We will maintain operations of our Sapphire Cryocooler cryogenics initiatives while ceasing additional manufacturing of our HTS Conductus® wire. The plan also included a 70% employee workforce reduction.

XML 26 R15.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Apr. 03, 2021

Accounting Policies [Abstract]

Schedule of Stock-Based Compensation Expense

The following table presents details of total stock-based compensation expense that is included in each functional line item on our condensed consolidated statements of operations:

	Three months ended
	April 3, 2021		March 28, 2020
Cost of commercial product revenues	$	-	$	1,000
Research and development		-		2,000
Selling, general and administrative		-		18,000
Total stock-based compensation expense	$	-	$	21,000

XML 27 R16.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

3 Months Ended

Apr. 03, 2021

Equity [Abstract]

Summary of Stockholders' Equity Transactions

The following is a summary of stockholders’ equity transactions for the three months ended April 3, 2021:

	Convertible								Capital in
	Preferred Stock				Common Stock				Excess of		Accumulated
	Shares		Amount		Shares		Amount		Par Value		Deficit			Total
Balance at December 31, 2020		328,925	$	-		3,151,780	$	3,000	$	334,632,000	$	(331,930,000	)	$	2,705,000
Merger partner contribution				-		-		-		120,000					120,000
Net loss												(569,000	)		(569,000	)
Balance at April 3, 2021		328,925	$	-		3,151,780	$	3,000	$	334,752,000	$	(332,499,000	)	$	2,256,000

The following is a summary of stockholders’ equity transactions for the three months ended March 28, 2020:

	Convertible								Capital in
	Preferred Stock				Common Stock				Excess of		Accumulated
	Shares		Amount		Shares		Amount		Par Value		Deficit			Total
Balance at December 31, 2019		328,925	$	-		1,773,189	$	2,000	$	330,474,000	$	(328,973,000	)	$	1,503,000
Warrant exercises				-		555,171		-		1,383,000					1,388,000
Stock-based compensation										21,000					21,000
Net loss												(1,079,000	)		(1,079,000	)
Balance at March 28, 2020		328,925	$	-		2,328,360	$	2,000	$	331,878,000	$	(330,052,000	)	$	1,833,000

Summary of Stock Option Transactions under Stock Option Plan

The following is a summary of stock option transactions under our Stock Option Plans at April 3, 2021:

	Number of Shares	Price Per Share		Weighted Average Exercise Price		Number of Options Exercisable		Weighted Average Exercise Price
Balance at December 31, 2020	7,863	$	19.20 - $ 28,440	$	255.90		7,863	$	255.90
Granted	-				-
Exercised	-				-
Canceled	12		28,440		28,440		12		28,440
Balance at April 3, 2021	7,851	$	19.20 - $ 26,280	$	211.24		7,851	$	211.24

Summary of Outstanding Warrants

The following is a summary of outstanding warrants at April 3, 2021:

	Common Shares
	Total		Currently Exercisable		Price per Share		Expiration Date

Warrants related to August 2016 financing		5,350		5,350	$	300.00		February 2, 2022
Warrants related to August 2016 financing		500		500	$	385.50		August 2, 2021
Warrants related to December 2016 financing		68,567		68,567	$	200.00		December 14, 2021
Warrants related to March 2018 financing		15,810		15,810	$	114.00		September 9, 2023
Warrants related to March 2018 financing		1,107		1,107	$	158.00		March 6, 2023
Warrants related to July 2018 financing		257,143		257,143	$	35.00		July 25, 2023
Warrants related to July 2018 financing		15,428		15,428	$	43.75		July 25, 2023
Warrants related to May 2019 financing		11,900		11,900	$	12.50		May 23, 2024
Warrants related to October 2019 financing		217,200		217,200	$	2.50		October 10, 2024
Warrants related to October 2019 financing		30,916		30,916	$	3.13		October 8, 2024

XML 28 R17.htm IDEA: XBRL DOCUMENT

Loss Per Share (Tables)

3 Months Ended

Apr. 03, 2021

Earnings Per Share [Abstract]

Schedule of Antidilutive Shares Computation of Earnings (Loss) Per Share

Since their impact would be anti-dilutive, our net loss per common share does not include the effect of the assumed exercise or vesting of the following shares:

	April 3, 2021		March 28, 2020

Outstanding stock options		7,851		12,141
Unvested restricted stock awards		-		33
Outstanding warrants		623,921		1,062,819
Total		631,772		1,074,993

XML 29 R18.htm IDEA: XBRL DOCUMENT

Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities (Tables)

3 Months Ended

Apr. 03, 2021

Text Block [Abstract]

Schedule of Components of Inventories

	April 3, 2021		December 31, 2020
Inventories:
Work In Process		68,000		68,000
	$	68,000	$	68,000

Schedule of Components of Property and Equipment

	April 3, 2021		December 31, 2020
Property and Equipment:
Equipment	$	316,000	$	316,000
		-
Less: accumulated depreciation and amortization		316,000		(316,000	)
	$	-	$	-

Schedule of Components of Patents and Licenses

	April 3, 2021			December 31, 2020
Patents and Licenses:
Patents issued		278,000			278,000
Less accumulated amortization		(278,000	)		(278,000	)
Net patents issued		-			-
	$	-		$	-

Schedule of Components of Accrued Expenses and Other Long Term Liabilities

	April 3, 2021			December 31, 2020
Accrued Expenses and Other Long Term Liabilities:
Salaries Payable	$	30,000		$	10,000
Compensated absences		-			125,000
		30,000			135,000
Less current portion		(30,000	)		(135,000	)
Long term portion	$	-		$	-

Schedule of Warranty Reserve Activity

	For the three months ended,
	April 3, 2021		March 28, 2020
Warranty Reserve Activity:
Beginning balance	$	-	$	8,000
Additions		-		-
Deductions		-		-
Ending balance	$	-	$	8,000

XML 30 R19.htm IDEA: XBRL DOCUMENT

General (Details Narrative) - USD ($)	Feb. 26, 2021	Feb. 26, 2020	Jan. 28, 2020
Aggregate sales prices			$ 1,075,000
Clearday Inc [Member] \| New Merger Agreement [Member]
Payment for merger related costs		$ 120,000
Clearday Inc [Member] \| New Merger Agreement [Member] \| Paycheck Protection Program Loan [Member]
Proceeds from loan	$ 468,000
Employee [Member]
Employee workforce reduction percentage			70.00%

XML 31 R20.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative) - USD ($)			3 Months Ended		12 Months Ended
	Sep. 09, 2020	Jul. 06, 2020	Apr. 03, 2021	Mar. 28, 2020	Dec. 31, 2020	Dec. 31, 2019	Sep. 10, 2020	Jan. 28, 2020
Summary Of Significant Accounting Policies [Line Items]
Accumulated deficit			$ (332,499,000)		$ (331,930,000)
Net loss			(569,000)	$ (1,079,000)	(2,957,000)	$ (9,229,000)
Cash flows from operations			(453,000)	(1,470,000)	(3,138,000)	(8,803,000)
Cash			$ 1,291,000		$ 1,276,000
Reverse split	1-for-10 reverse stock split
Net proceeds from sale of our common and preferred shares and warrants						3,900,000
Common stock shares authorised	250,000,000		25,000,000		25,000,000		25,000,000
Par value of common stock	$ 0.001		$ 0.001		$ 0.001
Inventories, net			$ 68,000		$ 68,000
Wire inventory expensed				190,000
Common stock issued		400,000
Preferred equity interest, value		$ 1,600,000
Purchase price		$ 4.00
Gain on sale of production wire equipment				$ 510,000
Minimum percentage of tax benefit realized			50.00%
Net operating loss carryforwards					$ 2,979,000
Operating loss carry forwards expiration date description					Expire in the years 2021 through 2038
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Net operating loss carryforwards					$ 14,200,000
Patents and Licenses [Member]
Summary Of Significant Accounting Policies [Line Items]
Impairment of intangible assets					$ 134,000
Employee [Member]
Summary Of Significant Accounting Policies [Line Items]
Employee workforce reduction percentage								70.00%

XML 32 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Stock-Based Compensation Expense (Detail) - USD ($)	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense		$ 21,000
Cost of commercial product revenues [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense		1,000
Research and Development Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense		2,000
Selling, General and Administrative Expenses [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense		$ 18,000

XML 33 R22.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Details Narrative) - USD ($)			3 Months Ended
Stockholders' Equity (Details Narrative) - USD ($)	Oct. 10, 2019	May 23, 2019	Apr. 03, 2021	Mar. 28, 2020	Dec. 31, 2019
Stock compensation cost				$ 21,000
Warrants exercise				$ 1,388,000
Stock Options [Member]
Basic net loss per common share			$ 0	$ 20,000
Diluted net loss per common share			$ 0.00	0.01
Stock compensation cost
Compensation cost related to nonvested awards not yet recognized			$ 0
Option contractual term			7 years 2 months 12 days
Exercisable contractual term			7 years 2 months 12 days
Options exercises in weighted average exercise price value			$ 1,700,000
Restricted Stock Awards [Member]
Basic net loss per common share			$ 0	1,000
Diluted net loss per common share			$ 0.00	$ 0.00
Stock compensation cost
Minimum [Member] \| Stock Options [Member]
Options exercises in weighted average exercise per price			$ 19.20
Maximum [Member] \| Stock Options [Member]
Options exercises in weighted average exercise per price			$ 26,280
Common Stock [Member]
Number of shares issued	1,183,400
Warrants to purchase common stock	1,183,400
Gross proceeds from common stock	$ 3,000,000
Warrants, exercisable period	5 years
Issuance price per share	$ 0.25
Net proceeds from common stock	$ 2,400,000
Common Stock [Member] \| Public Offering [Member]
Number of shares issued		170,000
Gross proceeds from common stock		$ 1,700,000
Issuance price per share		$ 10.00
Net proceeds from common stock		$ 1,400,000
Warrant [Member]
Warrants to purchase common stock	82,838
Exercise price of warrants	$ 3.125
Warrants maturity date	Oct. 08, 2024
Number of warrants exercised				555,171	39,528
Warrants exercise				$ 1,400,000	$ 99,000
Placement Agent Warrant [Member]
Warrants to purchase common stock		11,900
Exercise price of warrants		$ 12.50
Warrants maturity date		May 23, 2024

XML 34 R23.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Summary of Stockholders' Equity Transactions (Details) - USD ($)	3 Months Ended		12 Months Ended
	Apr. 03, 2021	Mar. 28, 2020	Dec. 31, 2020	Dec. 31, 2019
Balance		$ 1,503,000	$ 1,503,000
Merger partner contribution	$ 120,000
Warrant exercises		1,388,000
Stock-based compensation		21,000
Net loss	(569,000)	(1,079,000)	(2,957,000)	$ (9,229,000)
Balance	2,256,000	1,833,000	2,705,000	1,503,000
Common Stock [Member]
Balance		$ 2,000	$ 2,000
Balance, shares		1,773,189	1,773,189
Merger partner contribution
Warrant exercises
Warrant exercises, shares		555,171
Stock-based compensation
Net loss
Balance	$ 3,000	$ 2,000		$ 2,000
Balance, shares	3,151,780	2,328,360		1,773,189
Capital in Excess of Par Value [Member]
Balance		$ 330,474,000	$ 330,474,000
Merger partner contribution	$ 120,000
Warrant exercises		1,383,000
Stock-based compensation		21,000
Net loss
Balance	334,752,000	331,878,000		$ 330,474,000
Accumulated Deficit [Member]
Balance		(328,973,000)	(328,973,000)
Merger partner contribution
Warrant exercises
Stock-based compensation
Net loss	(569,000)	(1,079,000)
Balance	(332,499,000)	(330,052,000)		(328,973,000)
Convertible Preferred Stock [Member]
Balance
Balance, shares		328,925	328,925
Merger partner contribution
Warrant exercises
Stock-based compensation
Net loss
Balance
Balance, shares	328,925	328,925		328,925

XML 35 R24.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Summary of Stock Option Transactions under Stock Option Plan (Details) - Stock Option [Member] - Stock Option Plans [Member]	3 Months Ended
	Apr. 03, 2021 $ / shares shares
Number of Shares, Granted \| shares
Number of Shares, Exercised \| shares
Number of Shares, Canceled \| shares	12
Number of Shares, Ending balance \| shares	7,851
Price Per Share, Canceled	$ 28,440
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Ending Balance	$ 211.24
Number of Options Exercisable, Canceled \| shares	12
Number of Options Exercisable, Ending Balance \| shares	7,851
Weighted Average Exercise Price, Canceled	$ 28,440
Weighted Average Exercise Price, Ending balance	211.24
Minimum [Member]
Price Per Share, Canceled
Price Per Share, Ending balance	19.20
Maximum [Member]
Price Per Share, Canceled
Price Per Share, Ending balance	$ 26,280

XML 36 R25.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Summary of Outstanding Warrants (Details)	Apr. 03, 2021 $ / shares shares
Warrants Related to August 2016 Financing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	5,350
Currently Exercisable	5,350
Price per Share \| $ / shares	$ 300.00
Expiration Date	Feb. 02, 2022
Warrants Related to August 2016 Financing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	500
Currently Exercisable	500
Price per Share \| $ / shares	$ 385.50
Expiration Date	Aug. 02, 2021
Warrants Related to December 2016 Financing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	68,567
Currently Exercisable	68,567
Price per Share \| $ / shares	$ 200.00
Expiration Date	Dec. 14, 2021
Warrants Related to March 2018 Financing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	15,810
Currently Exercisable	15,810
Price per Share \| $ / shares	$ 114.00
Expiration Date	Sep. 09, 2023
Warrants Related to March 2018 Financing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	1,107
Currently Exercisable	1,107
Price per Share \| $ / shares	$ 158.00
Expiration Date	Mar. 06, 2023
Warrants Related to July 2018 Financing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	257,143
Currently Exercisable	257,143
Price per Share \| $ / shares	$ 35.00
Expiration Date	Jul. 25, 2023
Warrants Related to July 2018 Financing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	15,428
Currently Exercisable	15,428
Price per Share \| $ / shares	$ 43.75
Expiration Date	Jul. 25, 2023
Warrants Related to May 2019 Financing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	11,900
Currently Exercisable	11,900
Price per Share \| $ / shares	$ 12.50
Expiration Date	May 23, 2024
Warrants Related to October 2019 Financing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	217,200
Currently Exercisable	217,200
Price per Share \| $ / shares	$ 2.50
Expiration Date	Oct. 10, 2024
Warrants Related to October 2019 Financing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	30,916
Currently Exercisable	30,916
Price per Share \| $ / shares	$ 3.13
Expiration Date	Oct. 08, 2024

XML 37 R26.htm IDEA: XBRL DOCUMENT

Loss Per Share (Details Narrative)	3 Months Ended
Loss Per Share (Details Narrative)	Apr. 03, 2021 shares
Earnings Per Share [Abstract]
Convertible into shares of common stock	182

XML 38 R27.htm IDEA: XBRL DOCUMENT

Loss Per Share - Schedule of Antidilutive Shares Computation of Earnings (Loss) Per Share (Details) - shares	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Total	631,772	1,074,993
Outstanding Stock Options [Member]
Total	7,851	12,141
Unvested Restricted Stock Awards [Member]
Total		33
Outstanding Warrants [Member]
Total	623,921	1,062,819

XML 39 R28.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative)	3 Months Ended
Commitments and Contingencies (Details Narrative)	Apr. 03, 2021 USD ($) ft²	Mar. 28, 2020 USD ($)
operating lease expense	$ 0
Royalty expenses	$ 0	$ 11,000
Licensing Agreements [Member] \| Minimum [Member]
Royalty payments percentage	0.13%
Licensing Agreements [Member] \| Maximum [Member]
Royalty payments percentage	2.50%
Austin, Texas [Member]
Area of land \| ft²	94,000
Operating lease expiration date	Mar. 31, 2020

XML 40 R29.htm IDEA: XBRL DOCUMENT

Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Mar. 31, 2021	Apr. 03, 2021	Mar. 28, 2020	Dec. 31, 2020
Long term debt		$ 468,000
Depreciation expense		0	$ 27,000
Amortization expense		$ 0	$ 11,000
Paycheck Protection Program Loan [Member] \| CARES Act [Member]
Proceeds from loans	$ 468,000
Debt instrument interest rate	1.00%
Repayment of loan
Long term debt	$ 468,000

- Definition

Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.

+ References + Details

XML 41 R30.htm IDEA: XBRL DOCUMENT

Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Inventories (Details) - USD ($)	Apr. 03, 2021	Dec. 31, 2020
Text Block [Abstract]
Work-in-process	$ 68,000	$ 68,000
Inventories, net	$ 68,000	$ 68,000

XML 42 R31.htm IDEA: XBRL DOCUMENT

Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Property and Equipment (Details) - USD ($)	Apr. 03, 2021	Dec. 31, 2020
Property and Equipment, Gross
Less: accumulated depreciation and amortization	316,000	(316,000)
Property and Equipment, Net
Equipment [Member]
Property and Equipment, Gross	$ 316,000	$ 316,000

XML 43 R32.htm IDEA: XBRL DOCUMENT

Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Patents and Licenses (Details) - USD ($)	Apr. 03, 2021	Dec. 31, 2020
Patents gross
Less accumulated amortization	(278,000)	(278,000)
Patents and licenses, net
Patents Issued [Member]
Patents gross	$ 278,000	$ 278,000

XML 44 R33.htm IDEA: XBRL DOCUMENT

Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Accrued Expenses and Other Long Term Liabilities (Details) - USD ($)	Apr. 03, 2021	Dec. 31, 2020
Text Block [Abstract]
Salaries Payable	$ 30,000	$ 10,000
Compensated absences		125,000
Total	30,000	135,000
Less current portion	(30,000)	(135,000)
Long term portion

XML 45 R34.htm IDEA: XBRL DOCUMENT

Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Warranty Reserve Activity (Details) - USD ($)	3 Months Ended
	Apr. 03, 2021	Mar. 28, 2020
Text Block [Abstract]
Beginning balance		$ 8,000
Additions
Deductions
Ending balance		$ 8,000

XML 46 R35.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Narrative) - Subsequent Event [Member] - Merger Agreement [Member]	May 14, 2021
Clearday Inc [Member]
Business acquisition description	Clearday was incorporated on December 20, 2017 and commenced its business on December 31, 2018 when it acquired private funds that engaged in several businesses that have been conducted for the prior 15 years. Since December 2018,
Company's Stockholders [Member]
Equity ownership percentage	96.35%
Clearday Stockholders [Member]
Equity ownership percentage	3.65%

EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 100 270 1 false 45 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://suptech.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://suptech.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets Sheet http://suptech.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://suptech.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://suptech.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - General Sheet http://suptech.com/role/General General Notes 6 false false R7.htm 00000007 - Disclosure - Summary of Significant Accounting Policies Sheet http://suptech.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 00000008 - Disclosure - Stockholders' Equity Sheet http://suptech.com/role/StockholdersEquity Stockholders' Equity Notes 8 false false R9.htm 00000009 - Disclosure - Loss Per Share Sheet http://suptech.com/role/LossPerShare Loss Per Share Notes 9 false false R10.htm 00000010 - Disclosure - Commitments and Contingencies Sheet http://suptech.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 10 false false R11.htm 00000011 - Disclosure - Contractual Guarantees and Indemnities Sheet http://suptech.com/role/ContractualGuaranteesAndIndemnities Contractual Guarantees and Indemnities Notes 11 false false R12.htm 00000012 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities Sheet http://suptech.com/role/DetailsOfCertainFinancialStatementComponentsAndSupplementalDisclosuresOfCashFlowInformationAndNon-cashActivities Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities Notes 12 false false R13.htm 00000013 - Disclosure - Subsequent Events Sheet http://suptech.com/role/SubsequentEvents Subsequent Events Notes 13 false false R14.htm 00000014 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://suptech.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://suptech.com/role/SummaryOfSignificantAccountingPolicies 14 false false R15.htm 00000015 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://suptech.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://suptech.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Stockholders' Equity (Tables) Sheet http://suptech.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://suptech.com/role/StockholdersEquity 16 false false R17.htm 00000017 - Disclosure - Loss Per Share (Tables) Sheet http://suptech.com/role/LossPerShareTables Loss Per Share (Tables) Tables http://suptech.com/role/LossPerShare 17 false false R18.htm 00000018 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities (Tables) Sheet http://suptech.com/role/DetailsOfCertainFinancialStatementComponentsAndSupplementalDisclosuresOfCashFlowInformationAndNon-cashActivitiesTables Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities (Tables) Tables http://suptech.com/role/DetailsOfCertainFinancialStatementComponentsAndSupplementalDisclosuresOfCashFlowInformationAndNon-cashActivities 18 false false R19.htm 00000019 - Disclosure - General (Details Narrative) Sheet http://suptech.com/role/GeneralDetailsNarrative General (Details Narrative) Details http://suptech.com/role/General 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://suptech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://suptech.com/role/SummaryOfSignificantAccountingPoliciesTables 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies - Schedule of Stock-Based Compensation Expense (Detail) Sheet http://suptech.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfStock-basedCompensationExpenseDetail Summary of Significant Accounting Policies - Schedule of Stock-Based Compensation Expense (Detail) Details 21 false false R22.htm 00000022 - Disclosure - Stockholders' Equity (Details Narrative) Sheet http://suptech.com/role/StockholdersEquityDetailsNarrative Stockholders' Equity (Details Narrative) Details http://suptech.com/role/StockholdersEquityTables 22 false false R23.htm 00000023 - Disclosure - Stockholders' Equity - Summary of Stockholders' Equity Transactions (Details) Sheet http://suptech.com/role/StockholdersEquity-SummaryOfStockholdersEquityTransactionsDetails Stockholders' Equity - Summary of Stockholders' Equity Transactions (Details) Details 23 false false R24.htm 00000024 - Disclosure - Stockholders' Equity - Summary of Stock Option Transactions under Stock Option Plan (Details) Sheet http://suptech.com/role/StockholdersEquity-SummaryOfStockOptionTransactionsUnderStockOptionPlanDetails Stockholders' Equity - Summary of Stock Option Transactions under Stock Option Plan (Details) Details 24 false false R25.htm 00000025 - Disclosure - Stockholders' Equity - Summary of Outstanding Warrants (Details) Sheet http://suptech.com/role/StockholdersEquity-SummaryOfOutstandingWarrantsDetails Stockholders' Equity - Summary of Outstanding Warrants (Details) Details 25 false false R26.htm 00000026 - Disclosure - Loss Per Share (Details Narrative) Sheet http://suptech.com/role/LossPerShareDetailsNarrative Loss Per Share (Details Narrative) Details http://suptech.com/role/LossPerShareTables 26 false false R27.htm 00000027 - Disclosure - Loss Per Share - Schedule of Antidilutive Shares Computation of Earnings (Loss) Per Share (Details) Sheet http://suptech.com/role/LossPerShare-ScheduleOfAntidilutiveSharesComputationOfEarningsLossPerShareDetails Loss Per Share - Schedule of Antidilutive Shares Computation of Earnings (Loss) Per Share (Details) Details 27 false false R28.htm 00000028 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://suptech.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://suptech.com/role/CommitmentsAndContingencies 28 false false R29.htm 00000029 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities (Details Narrative) Sheet http://suptech.com/role/DetailsOfCertainFinancialStatementComponentsAndSupplementalDisclosuresOfCashFlowInformationAndNon-cashActivitiesDetailsNarrative Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities (Details Narrative) Details http://suptech.com/role/DetailsOfCertainFinancialStatementComponentsAndSupplementalDisclosuresOfCashFlowInformationAndNon-cashActivitiesTables 29 false false R30.htm 00000030 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Inventories (Details) Sheet http://suptech.com/role/DetailsOfCertainFinancialStatementComponentsAndSupplementalDisclosuresOfCashFlowInformationAndNon-cashActivities-ScheduleOfComponentsOfInventoriesDetails Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Inventories (Details) Details 30 false false R31.htm 00000031 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Property and Equipment (Details) Sheet http://suptech.com/role/DetailsOfCertainFinancialStatementComponentsAndSupplementalDisclosuresOfCashFlowInformationAndNon-cashActivities-ScheduleOfComponentsOfPropertyAndEquipmentDetails Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Property and Equipment (Details) Details 31 false false R32.htm 00000032 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Patents and Licenses (Details) Sheet http://suptech.com/role/DetailsOfCertainFinancialStatementComponentsAndSupplementalDisclosuresOfCashFlowInformationAndNon-cashActivities-ScheduleOfComponentsOfPatentsAndLicensesDetails Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Patents and Licenses (Details) Details 32 false false R33.htm 00000033 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Accrued Expenses and Other Long Term Liabilities (Details) Sheet http://suptech.com/role/DetailsOfCertainFinancialStatementComponentsAndSupplementalDisclosuresOfCashFlowInformationAndNon-cashActivities-ScheduleOfComponentsOfAccruedExpensesAndOtherLongTermLiabilitiesDetails Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Components of Accrued Expenses and Other Long Term Liabilities (Details) Details 33 false false R34.htm 00000034 - Disclosure - Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Warranty Reserve Activity (Details) Sheet http://suptech.com/role/DetailsOfCertainFinancialStatementComponentsAndSupplementalDisclosuresOfCashFlowInformationAndNon-cashActivities-ScheduleOfWarrantyReserveActivityDetails Details of Certain Financial Statement Components and Supplemental Disclosures of Cash Flow Information and Non-Cash Activities - Schedule of Warranty Reserve Activity (Details) Details 34 false false R35.htm 00000035 - Disclosure - Subsequent Events (Details Narrative) Sheet http://suptech.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://suptech.com/role/SubsequentEvents 35 false false All Reports Book All Reports scon-20210403.xml scon-20210403.xsd scon-20210403_cal.xml scon-20210403_def.xml scon-20210403_lab.xml scon-20210403_pre.xml http://fasb.org/srt/2021-01-31 http://xbrl.sec.gov/dei/2021 http://fasb.org/us-gaap/2021-01-31 true true ZIP 52 0001493152-21-012128-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-21-012128-xbrl.zip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end